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The Golgi complex serves as a vital organelle from which proteins and membrane lipids 
are modified, sorted, and trafficked to various destinations.  Mutations that cause defects in 
structural maintenance or membrane trafficking at the Golgi are commonly linked to 
neurodegeneration, metabolic disease, and reproductive disorders.  Both structural maintenance 
and membrane trafficking rely on cooperative efforts of coated vesicles and membrane tubules.  
Although extensive information is available for membrane coated vesicle traffic, knowledge of 
membrane tubules remains comparably deficient.  Understanding the regulatory mechanisms 
behind membrane tubules may help elucidate how Golgi tubule biogenesis can respond to 
varying physiological stimuli such as increased secretory loads. 
I utilized an siRNA library against all known and purported human kinases, or the 
kinome, in a high throughput, microscopy-based screen that identified proteins involved in 
Brefeldin A (BFA)-induced Golgi membrane tubulation.  This screen successfully identified 
siRNAs that significantly inhibited or enhanced the effects of BFA-induced Golgi tubulation.  
Among the identified hits, I further characterized two inhibitory siRNA that targeted Protein-
Associating with the Carboxyl-terminal domain of Ezrin (PACE1) and diacylglycerol kinase γ 
(DGK-γ), and determined that they play important roles in maintaining intact Golgi ribbon 
structures through regulating Golgi membrane tubule biogenesis.  I found that these proteins also 
facilitate Golgi reassembly and anterograde membrane trafficking of both soluble and 
transmembrane proteins, further buttressing the importance of membrane tubules in multiple, 
cellular processes.   
The results of my studies will be useful not only in contributing to the understanding of 
existing regulatory mechanisms behind membrane tubulation but also in discovering novel 
mechanisms.  Further studies on membrane tubulation will help shed light on physiological 
functions and possibly lead to translational advances in diseases that depend on membrane 
tubulation and/or trafficking. 
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CHAPTER 1 
 
Mechanisms of Membrane Trafficking§ 
 
 
 
 
 
 
 
 
 
 
 
§ This chapter includes work published in full, with modifications, from Kevin D. Ha, Benjamin 
A. Clarke, and William J. Brown.  Regulation of the Golgi complex by phospholipid remodeling 
enzymes.  Biochim Biophys Acta (BBA).  (2012).  The text is reprinted here with permission from 
the publisher, Elsevier. 
2 
 
1.1. Abstract 
 
Higher eukaryotic cells possess numerous membrane-delimited compartments such as 
early and late endosomes, endosomal recycling compartment (ERC), the Golgi complex, the 
trans-Golgi network (TGN), endoplasmic reticulum (ER), and lysosomes, among others.  These 
membranous compartments contain varying protein and lipid compositions that differ from each 
other and determine their physiological roles and functions.  Eukaryotic cells utilize membrane 
trafficking to effectively sort and transport proteins and membranes between these membrane 
compartments in order to carry out secretion and endocytosis and to maintain their homeostatic 
compositions.  Defects in membrane trafficking may yield an assortment of physiological 
diseases, including neurodegenerative and reproductive disorders.  Membrane trafficking 
intermediates comprise both vesicles and membrane tubules.  Both are similar in the respect that 
they participate in the trafficking of both protein and membrane cargo destined for diverse, 
intracellular destinations.  However, membrane tubules differ from membrane vesicles with 
respect to their formation, regulation, and function.  While extensive research has helped 
elucidate membrane vesicle biology in detail, comparable information is lacking on membrane 
tubule biology.  Recent studies discovered important proteins, chiefly phospholipases and 
acyltransferases, to be involved in membrane tubulation in addition to establishing the 
importance of membrane tubules in a variety of physiological functions.  Although these studies 
help clarify membrane tubule roles in membrane trafficking and Golgi structure maintenance, the 
biochemical regulation behind membrane tubulation remains largely uninvestigated.  Here, I will 
provide a broad overview on membrane trafficking followed by a detailed review on 
phospholipid remodeling-based membrane tubulation. 
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1.2. Introduction 
 
 Cargo proteins and membranes destined for transport to organelles are synthesized in the 
ER, then transported to the Golgi complex where protein cargo undergo post-translational 
modifications such as glycosylation, and finally sorted into membrane carriers destined to 
specific target membranes.  The Golgi complex is composed of stacks of flattened cisternae.  
Both the number of stacks and cisternae they contain vary between different organisms.  
Mammalian cells typically feature the Golgi complex as a single, long stack, called a Golgi 
ribbon, in a juxtanuclear position, although certain cell types such as neuronal dendrites utilize 
Golgi stacks positioned far from the nucleus, called Golgi outposts [1], while skeletal muscle 
myofibers display dispersed Golgi structures [2].  The cisternal Golgi element closest to the 
nucleus and ER is called the cis-Golgi cisterna while the opposite end of the stack is the trans-
Golgi cisterna.  At the trans-face of the Golgi complex, cisternae display higher plasticity and 
become tubular and vesicular.  The TGN lies further trans from the Golgi stack and bears an 
extensive tubulovesicular morphology [3], and this morphology may be due to the gradual 
segregation of proteins and membranes destined for differing compartments via its consumption 
by coated vesicle and membrane tubule formation [2]. Similar to the TGN, the ER-Golgi-
intermediate compartment (ERGIC) resides between the Golgi stack and the ER and also 
assumes a tubulovesicular cluster morphology [4]. 
 A protein destined for secretion typically bears a hydrophobic signal sequence (SS) on its 
N-terminus, which is recognized by the signal-recognition particle (SRP) during nascent 
translation and then directs the peptide along with its translational machinery to the ER [5].  SRP 
arrests protein translation when it binds to the SS [6], but upon binding to the SRP receptor, it 
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dissociates and permits translation to resume with the ribosome now bound to a protein that 
directs nascent proteins across membranes, called the translocon [7].  Protein cargo is then sorted 
and packaged into COPII vesicles in specific sites within the ER called ER exit sites (ERESs), 
which then send protein and membrane cargo towards the ERGIC [8].  Interestingly, ERESs 
appear to have distinct cargo [9], further demonstrating that the ER, along with the Golgi, 
possesses sorting abilities.  The ERGIC also serves to further sort protein cargo by separating 
proteins destined for the Golgi from proteins to be returned back to the ER [10-11].   
 
1.3. Models of intra-Golgi trafficking 
 
Once at the cis-Golgi cisterna, protein and membrane cargo make their way towards the 
trans-Golgi cisterna.  The mechanism by which this occurs remains a heavily contentious issue.  
One early model proposed by Dr. George Palade, called the forward vesicular-trafficking or 
stable compartments model, is based on the idea that Golgi cisternae remain static while protein 
and membrane cargo must travel across the sequential cisternae of the Golgi stack by means of 
successive vesicle budding and fusion events that were assumed to move in an anterograde 
direction [12].  However, later biochemical, genetic, and cell biological studies refuted this 
model, leading to the more widely accepted model that  COPI vesicles mediate retrograde 
trafficking through and from the Golgi [13].  For example, purified intra-Golgi COPI vesicles 
possess Golgi resident proteins and not cargo [14].  Furthermore, many organisms transport 
protein cargos that do not fit in conventional COPI vesicles, such as procollagen in mammalian 
fibroblasts [15-16]. 
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This led to the proposal of a second model, called the Golgi maturation model, where cis-
Golgi cisternae mature into trans-Golgi cisternae while Golgi resident proteins, such as 
glycosylation enzymes, are recycled back to cis-Golgi cisternae via COPI coated vesicles [17].  
The Golgi maturation model is best supported by live-cell imaging studies which showed that 
early Golgi markers are replaced with later Golgi markers within the same Golgi element [18-
19].  In the maturation model, incoming protein must undergo a lag phase after entering the 
Golgi cis-cisterna to allow time for retrograde, vesicular traffic of Golgi resident enzymes from 
mature trans-cisternae to arrive and modify the cargo proteins.  However, later studies analyzing 
the kinetics of cargo transport in living cells using fluorescently-tagged proteins observed that 
proteins entering the Golgi did not exhibit any lag phase and instead, their rate of exit depending 
on their abundance within the Golgi [20].   
This heralded a third model of intra-Golgi trafficking by the Lippincott-Schwartz 
laboratory, which postulates that both protein cargo and Golgi resident enzymes can move 
bidirectionally, both cis-to-trans and trans-to-cis within Golgi stacks.  This model additionally 
depends on the sorting of lipids into different domains at each level of the Golgi and that proteins 
associate with specific lipid environments [21].  Some protein cargo at the trans-Golgi cisternae 
is packed into COPI vesicles destined for retrograde traffic [22], while anterograde cargo protein 
within the TGN is sorted and packaged into secretory vesicles for transport to endosomal 
compartments, such as the ERC [23-24].  Once at the ERC, proteins are further sorted to 
destinations such as the plasma membrane [25].  Although the Golgi complex has been 
considered a major hub for protein sorting, protein cargo can be sorted prior to arriving and/or 
after leaving the Golgi complex [2].  An example includes the endosomal recycling 
compartment, which sorts both endocytic and TGN-derived protein cargo to be recycled or 
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degraded [26].  Although the Golgi is considered the major hub for protein trafficking and 
sorting, some proteins are capable of bypassing entry into the Golgi during trafficking under 
“unconventional pathways”  [27-29]. 
When scrutinizing the membrane carriers themselves, decades of research have 
established a firm understanding in the biochemical mechanisms behind coated vesicle 
biogenesis and functions [30].  In contrast, comparably little is known about membrane tubules 
[31]. 
 
1.4. Significance of membrane tubules 
 
 Membrane tubules have fascinated cell biologists since the discovery that a fungal 
metabolite, Brefeldin A (BFA), can readily induce the formation of tubules from the Golgi 
complex [32].  With technological advancements in both fluorescence and electron microscopy, 
it became clear that dynamic, endogenous, membrane tubules exist.  They were observed to be 
originating from many organelles including the ER, ERGIC [33], Golgi [34-37], TGN [38], 
endosomes [39], and plasma membrane [40] in diverse organisms from yeast to humans.   
Membrane tubules are significant in membrane trafficking as they originate from many 
organelles for trafficking routes (Figure 1.1).  In the ER, maintenance of membrane tubules may 
serve as a structural feature although they may also facilitate ER protein sorting and trafficking 
[41].  Membrane tubules also emanate from the plasma membrane to form contacts between 
animal cells, providing a way for intercellular communication or facilitating the spread of 
pathogens [42].  Prominent membrane tubules also originate from the Golgi and are extremely 
dynamic, where they are able to grow, shrink, and detach to traverse across the cell [43-44]. 
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Some of the first studies exploring the mechanism behind membrane tubule biogenesis 
began through analyzing BFA.  Studies have shown that BFA acts as an ADP-ribosylation factor 
(ARF) GTPase exchange factor (GEF) inhibitor to disrupt coated vesicle formation, such as 
COPI and AP-1 clathrin-coated vesicles, at the Golgi complex [45-46].  This inhibition 
stimulates Golgi membrane tubules that traffic in a retrograde fashion along microtubules to fuse 
with the ER [47-49].  This initially led to speculation that membrane tubulation may simply be 
an artifact of failed coated vesicle formation such as COPI, COPII, and AP-1 clathrin [32].  
Evidence against this possibility was provided by previous studies that have shown that RNAi 
knockdown of Golgi ARFs [50], some of their GEFs such as GBF1 [51], and AP-1 associated 
GGA1 (Golgi-localized, γ-ear containing, ARF-binding) [52] also induced membrane tubule 
formation.  Likewise, another study showed that addition of low-ATP cytosol can also induce 
membrane tubules in vitro using isolated, intact Golgi membranes [53].   
The observation that loss of coat proteins can induce membrane tubulation inferred that 
membrane tubule-based trafficking pathways might exist independently from coat proteins.  
Nevertheless, membrane tubulation and coat vesicles may not be mutually exclusive but can 
instead work in concert to facilitate membrane trafficking [54].  Some have even proposed that 
membrane tubules help increase Golgi fenestration, a widely observed morphology on the 
fringes of cisternae that helps to increase surface area to volume ratio and serve as precursors to 
membrane vesicles [55].  Both membrane tubulation and vesiculation require the preliminary 
step of inducing membrane curvature in order to form the vesicle or tubule membrane bud.  
Multiple mechanisms have been proposed to induce membrane curvature [56-59].  These 
mechanisms include changes to lipid structures within membrane bilayer leaflets, insertion of 
proteins  into  membrane  bilayer  or  leaflet,  and the  formation of  protein  scaffolds  alongside  
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Figure 1.1.  Illustration of membrane tubules participating in numerous trafficking routes. 
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membranes.  We have a deep understanding on the involvement of proteins that insert into or 
bind to membranes to induce curvature [60], but we are only beginning to understand how lipid-
remodeling enzymes function in membrane tubulation [31, 61-62].  
 
1.5. Involvement of lipid-modifying enzymes in membrane tubulation 
 
The importance of lipid changes within membranes is exemplified by the discovery that 
cytoplasmic phospholipases may play roles in inducing membrane tubulation to facilitate 
trafficking events, possibly by altering the physical structures of lipids in single leaflets of a 
membrane bilayer to induce membrane curvature, and thus membrane tubules [31].  For 
example, phospholipase A2 (PLA2) enzymes can alter phospholipid (PL) shapes by virtue of 
cleaving acyl chains from sn-2 positions of PLs to generate membrane tubules that facilitate 
membrane trafficking and structural homeostasis at the Golgi [34, 37].  Intra-Golgi membrane 
tubules may possibly permit bidirectional transport of both soluble and membrane-bound 
proteins [55].  Interestingly, modulation of PL shapes can also be catalyzed by lysophospholipid 
acyltransferases (LPATs) that carry out the reverse reaction of PLA2s by transferring fatty acids 
onto lysophospholipids (LPLs), which subsequently contributes to trafficking and Golgi 
homeostasis [63-64].  Furthermore, PLAs and LPATs may provide both individual and concerted 
functions in extending, shrinking, and fission of membrane tubules to generate membrane 
vesicles. 
The roles of lipid-modifying enzymes in membrane tubules are not limited within Golgi 
membranes as other studies showed evidence that phospholipases also induce membrane tubules 
among the ERGIC and endosomes [33, 39].  Although these phospholipases may bear a common 
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mechanism in generating membrane tubules, their distinct localizations may help generate 
membrane tubules of diverse origins to accommodate numerous membrane trafficking pathways.   
 
1.6. Review of lipid-modifying enzymes in Golgi membrane dynamics 
   
The mammalian Golgi complex is an iconic structure consisting of stacks of flattened 
membrane cisternae that are dynamically modified by the formation of coated vesicles and 
membrane tubules [58, 65-68].  In addition, the cisternal stacks are often bridged together by 
membrane tubules into large ribbon-like structures, often forming a single interconnected 
organelle [69-70].  The coated vesicles and membrane tubules mediate cargo import and export 
events, which by their combined activities help to shape the architecture and polarity of the Golgi 
complex, and contribute to bidirectional trafficking of cargo across the cisternal stacks.  
Although numerous structural, scaffold, fusion, and tethering proteins, e.g., COPI and AP-1 
clathrin coats, GRASP, SNARE proteins, etc., have been shown to be crucial elements that 
regulate the functional organization of the Golgi complex, many fundamental questions about 
how the Golgi works remain unanswered, e.g., how secretory proteins move from the cis to the 
trans side of the Golgi stack [71].  Our lack of understanding is primarily due to the integrated 
and dynamic nature of the Golgi membranes, which makes it difficult to alter only a single 
aspect of Golgi trafficking without affecting every other.  Recently, the dynamic functional 
organization of the mammalian Golgi complex has been reported to involve continual 
phospholipid remodeling by the opposing actions of phospholipase A (PLA) and 
lysophospholipid acyltransferase (LPAT) enzymes, a process in which acyl chains are 
continually removed and reincorporated (Figure 1.2) [62, 72].  In other words, dynamic 
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remodeling of Golgi membrane phospholipids is thought to play a role in shaping the structure of 
the Golgi complex itself.  This review will focus on how these recently identified enzymes 
contribute to the dynamic nature of the mammalian Golgi complex.  
In the 1960’s Lands and colleagues established that after their synthesis, glycerol 
phospholipid acyl chains turnover in a cycle of deacylation and reacylation catalyzed by the 
opposing actions of PLA and LPAT enzymes, respectively, in what is now called the Lands 
cycle (Figure 1.2) [73-74].  The turnover of acyl chains serves to remodel phospholipids and thus 
alter their functional properties, although the full extent of the Lands cycle role in cells is 
unclear.  Nevertheless, several functions of the Lands cycle have been established including the 
incorporation and release of arachidonic acid (AA) for the production of eicosanoids and 
prostaglandins [75], production of platelet activating factor (PAF) [76-78], and the incorporation 
of host-derived fatty acids into membrane phospholipids in Giardia and other intracellular 
parasites [79]. Here we describe recent studies which suggest that Lands cycle phospholipid 
remodeling might regulate the functional organization of the Golgi complex.  
The mammalian Golgi complex, including the ER-Golgi-Intermediate Compartment 
(ERGIC) and trans-Golgi Network (TGN), produces types of membrane cargo transporters such 
as COPI and AP-1 clathrin-coated vesicles, regulated secretory granules, and constitutive 
secretory vesicles, whose function and biogenesis have been extensively studied (Figure 1.3) 
[23-24, 80-82].  For example, COPI coated vesicles mediate retrograde trafficking from the 
Golgi complex and ERGIC, whereas AP-1 coated vesicles mediate the sorting, packaging, and 
transport of newly synthesized lysosomal enzymes from the TGN to endosomes [80, 82-83].  
Membrane tubules of uniform diameter (60-80 nm) have also been observed to emanate from 
different regions of the Golgi complex (Figure 1.3), but in contrast to coated vesicles, much less 
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is known about their functions, and indeed, even their existence or prevalence under normal 
conditions is a matter of debate [58, 71, 84].  For example, although the ERGIC and TGN exhibit 
extensive membrane tubulation, the cisternal membranes of the Golgi stack proper generally 
have few tubules.  When viewed by 3-D tomographic reconstructions, membrane tubules are 
observed to link cisternal stacks into intact ribbons, but they are often not prominently seen in 
static images to extend out into the cytoplasm [58, 85-88].  Rather, Golgi membrane tubules are 
most readily observed when coated vesicle formation is inhibited or when GFP-tagged proteins 
are overexpressed for live cell imaging experiments [89-93], leading to concerns that they are 
only seen under unusual conditions.  However, recent studies have revived the idea that COPI 
(and perhaps AP-1) coated vesicles are intimately linked to the formation of membrane tubules 
[54], and that membrane tubules can perform trafficking functions independent of coated 
vesicles, both of which utilize Golgi-associated PLA2 and LPAT remodeling enzymes [62]. 
The relationship between Golgi complex coated vesicles and membrane tubules has 
puzzled cell biologists since the discovery of the remarkable properties of brefeldin A (BFA) 
[90, 93-96].  BFA is an inhibitor of guanine nucleotide exchange factors (GEFs) for certain 
ADP-ribosylation factor (ARF) GTPases [97-99], which prevents the recruitment of COPI 
coatomer and AP-1 subunits to Golgi and TGN membranes and the formation of COPI and AP-1 
coated vesicles [97, 100-101].  As a consequence, Golgi and TGN membranes form extensive 
numbers of membrane tubules [90, 93, 95-96, 102].  Interestingly, BFA-induced membrane 
tubules move in the same directions as the coated vesicles that would normally form, i.e., 
retrograde back to the ER and anterograde from the TGN to endosomes.  These studies suggested 
that BFA-induced membrane tubules are exaggerated forms of membrane protrusions that would 
normally be used to produce coated vesicles [94].  These original observations on the effects of 
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BFA were followed by a period when little progress was made on understanding the exact nature 
of Golgi membrane tubules.  More recently, however, several studies have shown that RNAi 
knockdown of Golgi ARFs [50], some of their GEFs such as GBF1 [51], and AP-1-associated 
GGA1 (Golgi-localized, γ ear-containing, ADP ribosylation factor-binding) [103] also induced 
membrane tubule formation.  These results are consistent with original ideas about the BFA 
effect, which are that membrane tubules reflect an inherent capacity of Golgi membranes to 
generate curvature, which if not used to make COPI or AP-1 coated vesicles, will continue to 
form abnormally long membrane tubules [94, 104].  Thus, the Golgi complex has an underlying 
COPI- and AP-1-independent mechanism capable of initiating membrane curvature, which 
recent studies report include PLA2 enzymes that associate with the cytoplasmic side of Golgi 
membranes. 
Although COPI vesicle formation has been extensively examined, there is no clear 
consensus on the exact molecular mechanisms [82, 105].  A variety of in vitro reconstitution 
studies have shown that COPI vesicles can be produced on artificial liposomes with purified 
coatomer subunits and ARF1-GTP [80, 105-107], indicating that these components represent the 
minimal machinery required for COPI vesicles biogenesis.  In particular, ARF1-GTP, which is 
required for recruiting the coatomer subunits for vesicle budding, has also been reported to be 
sufficient to mediate the fission step for release of a free vesicle [107].  ARF1 could induce 
membrane fission by virtue of its energetically favorable interaction with positively curved 
membranes and its unfavorable interaction with the negatively curved bud neck, which makes 
resolution of the fission event energetically attractive [105].  In addition to this minimal system, 
a variety of other proteins have been reported to participate in COPI vesicle fission.  For 
example, incubation with ARFGAP1, phospholipase D (PLD), and brefeldin A-ribosylated 
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substrate (BARS) have been shown stimulate the completion of membrane fission [108-112].  It 
is not clear how ARFGAP1 promotes budding or if ARFGAP1 is a stoichiometric component of 
the budded vesicle because it was recently reported that in vitro COPI vesiculation in the 
presence of GTP but lacking ARF GEFs is inhibited by enzymatic concentrations of ARFGAP1 
[113].  The ARF1-GTP stimulated action of PLD has also been reported to contribute to vesicle 
fission by hydrolyzing phosphatidylcholine (PC) to phosphatidic acid (PA), which could aid in 
producing negative curvature and recruiting BARS at the bud neck [114-116].  Although BARS 
and PLD may not be required in the minimal machinery for COPI vesicle formation, they could 
enhance the efficiency of COPI budding in vivo (discussed further below).   
 
1.7. PLA and LPAT enzymes remodel phospholipids and the Golgi complex 
PLA enzymes cleave acyl chains from phospholipids to yield a lysophospholipid (LPL) and a 
free fatty acid (Figure 1.2).  PLA enzymes are subdivided by their specificity to the sn-1 (PLA1) 
and sn-2 (PLA2) position of phospholipids; some cross-specificity has been observed [117].  
Nine PLA1 enzymes have been identified in mammals, six of which are extracellular proteins of 
the pancreatic lipase family; the remaining are intracellular lipases unrelated to pancreatic lipase 
[118].  The mammalian PLA2 superfamily comprises 14 groups of enzymes (Group I, II, etc.), 
which are distinguished by their cellular locations, substrate specificities, and Ca2+ dependence 
[75].  The sn-2 position of phospholipids in mammalian cells can be enriched in AA, which plays 
critical roles in many signal transduction pathways ranging from inflammation to mitogenesis 
[119].  Indeed, the diverse PLA2 superfamily plays important roles in myriad physiological 
processes such as reproduction, inflammation, heart disease, Alzheimer’s disease, and cancer 
[120-122].  Although most current literature primarily cite PLA2 enzymes for their roles in 
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inflammation, support for other functions is provided by recent studies showing that cytoplasmic 
PLA2 enzymes regulate membrane trafficking. 
The first indication that cytoplasmic PLA2 enzymes play a role in vesicle and membrane 
tubule biogenesis came from studies of pharmacological PLA2 inhibitors in cultured mammalian 
cells [62, 123-124].  PLA2 inhibitors block intra-Golgi protein trafficking in cell-free 
reconstitution systems, thus implicating the requirement for PLA2 activity at the Golgi complex 
[125].  More specifically, cytoplasmic PLA2 enzymes appear to play critical roles in forming 
membrane tubules, as inhibitory PLA2 drugs block BFA-induced membrane tubulation and 
trafficking in these organelles [124, 126].  Conversely, PLA2 stimulating peptides melittin and a 
peptide from a mammalian protein containing a melittin homology domain, PLA2 activating 
protein peptide (PLAAp), enhance cytosol-dependent Golgi membrane tubulation in vitro [127], 
possibly by embedding within the hydrocarbon region of membranes to facilitate PLA2 activity.  
A potential link between the catalytic lipase activities of PLA2 enzymes and membrane 
tubulation is supported by a hypothesis that the conversion of cylindrically-shaped phospholipids 
to conically-shaped products in local regions of a single leaflet of a lipid bilayer forces the 
membrane to adopt a curved structure, thus facilitating the formation of membrane tubules 
(Figure 1.2) [123].  Indeed, diverse lipid components alone can induce membrane curvature as 
observed in fluorescent, giant unilamellar vesicles [128]. 
In the context of the Lands cycle, LPATs oppose the action of PLA enzymes (Figure 1.2).  
LPATs catalyze the transfer of a fatty acid from an acyl-CoA donor to a LPL, most commonly at 
the sn-2 position, to yield a phospholipid.  Mammalian LPATs comprise two gene families of 
transmembrane proteins, 1-acylglycerol-3-phosphate acyltransferase (AGPAT) and membrane  
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Figure 1.2. A simple model of Lands cycle phospholipid remodeling by PLA2 and LPAT 
enzymes and how their phospholipid products can generate membrane curvature based 
on their physical shapes.  
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bound O-acyltransferases (MBOAT) [129-131].  The catalytic activities and substrate 
specificities of their gene products are not entirely characterized; however, 14 or more members 
are expected to have more than nominal LPAT activity.  These enzymes are also categorized, 
and sometimes named, according to substrate preferences, e.g., enzymes that produce PA from 
lysophosphatidic acid (LPA) are referred to as LPAATs; enzymes that produce PC are referred to 
as LPCATs [132].  Most LPATs are ER or mitochondria localized; AGPAT3/LPAAT3 is 
exceptional and also localizes to the Golgi complex [63]. 
The individual activities of PLA and LPAT enzymes to remodel membrane lipids has 
been extensively studied in terms of lipid homeostasis, inflammation, and signal transduction.  
Emerging evidence, from multiple independent studies, support an additional role for lipid 
remodeling in membrane trafficking of the Golgi complex, as well as other organelles.  The 
exact molecular mechanisms responsible for LPAT mediated trafficking are still unknown.  One 
possibility is that the interconversion of phospholipids and LPLs confers negative and positive 
curvature respectively, directly to membranes.  This curvature promotes the formation of tubular 
and/or vesicular membrane carriers (Figures 1.4 and 1.5) [59, 123, 128].  Another possibility is 
that compartment-specific PLA and LPAT activity produces a concentration gradient of lipid 
species that recruit effector proteins, such as COPI and clathrin coats (discussed further below).  
This recruitment model has many parallels to the extensively studied phosphoinositide phosphate 
(PIP) remodeling system [133].  It should be noted that lipid curvature and effector recruitment 
models are not mutually exclusive. 
The localized synthesis, remodeling, and selective partitioning of phospholipids, as well 
as cholesterol, sphingolipids, and plasmalogens throughout the secretory system create 
tremendous potential for membrane heterogeneity and complexity [134].  The maintenance of a 
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gradient of lipid species between membrane compartments is crucial to and assisted by the 
selective partitioning of protein and lipid cargoes into anterograde- and retrograde-bound 
vesicles and membrane tubules [21].  Curved membranes tend to exclude sphingolipids and are 
enriched in phospholipids.  For instance, in vitro reconstitution of COPI budding has shown that 
phase transition of phospholipid enriched domains is prevented at bud sites [106].  Phospholipid 
transfer proteins, flippases, PIPs, and, DAG also play important roles in the dynamic 
organization of the Golgi complex but are beyond the scope of this review [112, 133, 135-141]. 
Adding to this cast of phospholipid remodelers, the past two years have seen the 
identification of four specific cytoplasmic PLA and one integral membrane LPAT enzyme that 
play roles in the dynamic functional organization of the Golgi complex (Table 1.1).  Although 
these enzymes can individually catalyze changes in membrane phospholipids, it has not yet been 
directly demonstrated that any pair of PLA and LPAT enzymes are functionally coupled in a 
Lands cycle of phospholipid remodeling.  In any case, it is likely that these discoveries herald 
many more reports of PLA and LPAT enzyme involvement in Golgi membrane trafficking, and 
other compartments of the secretory and endocytic pathways. 
 
1.7.1. PAFAHIb 
One of the first PLA2 members discovered to be directly involved in membrane 
tubulation and trafficking are the two members of Group VIII PLA2s, also known as platelet 
activating factor acetylhydrolase (PAFAH) Ib 2 and 3.  These two PLA2 enzymes, called α1 
(gene name PAFAHIb2) and α2 (gene name PAFAHIb3), are Ca2+-independent and may form 
either homo- or hetero-dimers to form a catalytic pocket for the phospholipid substrate (Table) 
[142].  Both subunits within the dimer harbor a conserved GXSXG sequence and contribute  
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Class Gene Name Features 
PLA Enzymes 
PAFAHIb Has two Ca2+-independent PLA2 subunits, 
potentially links membrane tubules to 
microtubules, affects Golgi structure and 
trafficking, also regulates endocytic recycling 
cPLA2α Ca2+-dependent PLA2, maintains Golgi 
structure, provides intra-Golgi connections 
PLA2G6/iPLA2-β A cytoplasmic PLA2 associated with the 
ERGIC and regulates it structure/function 
iPLA1γ A cytoplasmic PLA1 enzyme located to 
cis/medial Golgi cisternal and influences 
anterograde trafficking 
LPATs AGPAT3/LPAAT3 An integral membrane LPAT of both the ER 
and Golgi complex that regulates both Golgi 
structure and trafficking 
 
Table 1.1.  Table of phospholipid remodeling enzymes at the Golgi complex 
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critical residues to the catalytic pocket, where the loss of the serine is sufficient to abolish the 
lipase activity [143].  The catalytic dimers also associate with a non-catalytic, regulatory β-
subunit also known as Lis1 (gene name PAFAHIb1), which is the causative gene for a 
neurodegenerative disorder called Miller-Dieker lissencephaly [144].  Lis1 is better known for its 
role in regulating dynein-mediated, microtubule-dependent transport [145-146].  Lis1 appears to 
inhibit minus-end directed movement of dynein, and with the help of kinesin, the Lis1/dynein 
complex undergoes anterograde transport to the plus-end of microtubules, where the dynein-
associated proteins, Nde1 or Ndel1, bind to the Lis1/dynein complex and mediate cargo transport 
back towards the minus ends of microtubules [147].  Nde1 and Ndel1 thus permit the compact 
accumulation of Lis1 in a juxtanuclear region where the minus ends of microtubules converge 
near centrosomes and indeed, mouse cells lacking Ndel1 show a cytoplasmic dispersed 
distribution of Lis1 [148].  Thus, Lis1 has dual, but not completely separate, roles in Golgi 
membrane dynamics via PAFAHIb-dependent phospholipid modification and dynein-mediated, 
microtubule-dependent transport. 
Interestingly, the possible combinations of catalytic dimers between α1 and α2 exhibit 
different substrate specificities and are differentially regulated by Lis1 [149].  Differences 
between α1 and α2 are punctuated by the observation that in rats, α1 is only expressed in 
developing, neonatal neurons and α2 is conversely expressed in both neo- and post-natal stages 
and is not limited to neural tissues [150]. 
All three members of the PAFAHIb group contribute to the maintenance of Golgi 
architecture (Figure 1.3, steps 1 and 2) [34].  This was first shown when biochemical 
fractionation of bovine brain cytosol identified all three subunits as cofractionating with PLA2 
activity and Golgi membrane tubulation in an in vitro reconstitution assay.  Importantly, purified  
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Figure 1.3. Membrane trafficking pathways from and within the mammalian Golgi 
complex.  Several studies have recently reported that four cytoplasmic PLA enzymes are 
associated with the Golgi complex and regulate trafficking in various ways.  As shown in Step 1, 
the cytoplasmic PLA2 enzyme PAFAHIb induces membrane tubules from the Golgi complex 
that contribute to the formation of an intact ribbon structure. In addition, PAFAHIb also appears 
to influence anterograde trafficking fromthe TGN (Step 2). A second cytoplasmic enzyme, 
cPLA2α,mediates the formation of intra-cisternal membrane tubules that appear to facilitate 
anterograde transportwhen the Golgi complex receives a large bolus of secretory cargo (Step 3). 
In addition, cPLA2 may also negatively regulate COPI coated vesicle formation (Step 4), perhaps 
by shifting the balance toward membrane tubule formation.  A third cytoplasmic PLA2, 
PLA2G6, was shown to mediate the formation of membrane tubules from the ERGIC, which 
may be important for connecting regions involved in COPI vesicle budding (Step 5). The final 
PLA enzyme recently found associated with ERGIC and Golgi membranes is iPLA1γ, which 
appears to contribute to anterograde transport through the Golgi complex by an unknown 
mechanism. 
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catalytically active, but not inactive α1 and α2 can induce Golgi membrane tubulation in vitro, 
and both α1 and α2 partially localize to the Golgi cisternae and the TGN in vivo.  PAFAHIb α1 
and α2 recruitment to Golgi membranes may be PIP dependent, as α1 appears to have a strong 
affinity for PI(4)P in protein-lipid overlay assays [151], and PI(4)P is known to be enriched 
within Golgi membranes [133].  Knockdown and over-expression studies demonstrated that both 
Lis1 binding and the PLA2 activities of α1 and α2 are important for regulating Golgi structure 
and function.  For example, knockdown of α1 and α2 caused the Golgi ribbon to fragment into 
separated mini-stacks, which could result from both loss of PLA2 activity that is required to 
generate membrane tubules and Lis1-regulated, dynein-mediated movement of Golgi mini-stacks 
to the cell center [152-153].  This idea is supported by the finding that Golgi mini-stacks 
produced following Lis1 knockdown are still able to generate membrane tubules, whereas mini-
stacks in α1/α2 knockdown cells cannot [34].  Likewise, the loss of either Nde1 or Ndel1 also 
leads to the dispersal of the Golgi complex [154].  Although it is tempting to hypothesize that a 
compact, juxtanuclear Golgi structure can be achieved by α1/α2 establishing a link between 
Golgi membrane tubules and Lis1/dynein/Nde1/Ndel1, other reports demonstrate that α1/α2 
directly compete with Ndel1 and dynein for Lis1 binding (Figure 1.6) [155].  Indeed, Lis1 
undergoes stark, conformational changes when it switches from a complex with a α2/α2 
homodimer to one with Ndel1 [156]. 
In addition to regulating membrane tubulation from the Golgi complex, PAFAHIb has 
been shown to have similar activity on early endosomes and the endocytic recycling 
compartment [151].  Moreover, PAFAHIb contributes to efficient endocytic recycling of 
transferrin and transferrin receptors.  Thus, PAFAHIb functions at multiple intracellular 
compartments [62]. 
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The discovery that PAFAHIb regulates Golgi structure and function is somewhat 
surprising given that it has a very strong substrate preference for PAF, which has an acetyl group 
in the sn-2 position and is best known as a potent extracellular mediator of platelet activation and 
inflammation [157-158].  How then could PAFAHIb be involved in Golgi dynamics?  First, 
PAFAHIb is a cytoplasmic enzyme, which due to its location is unavailable to hydrolyze 
extracellular PAF, and, moreover, mice knockout studies show that it is not the key enzyme 
responsible for turnover of extracellular PAF, a function most likely carried out by an unrelated, 
secreted PAFAH [157-160].  Second, PAFs possibly have other roles in cells because they are 
ubiquitously found in intracellular membranes, including those of Saccharomyces cerevisiae 
[161].  The relevant question for Golgi structure/function is how can PAFAHIb change 
membrane shape since PAF is structurally similar to LPLs?  One possibility is that in vivo 
PAFAHIb hydrolyzes unidentified substrates.  Another possibility is that PAF is nevertheless 
sufficiently different from LPLs to help generate outward membrane curvature when hydrolyzed 
on the cytoplasmic leaflet of Golgi membranes.  Reconstitution experiments using defined 
phospholipid compositions will be required to definitively address these issues. 
 
1.7.2. cPLA2α 
Another PLA2 member, a cytoplasmic Group IV PLA2 named cPLA2α (gene name 
PLA2G4A) also exerts effects on membrane dynamics at the Golgi complex (Table).  cPLA2α is 
one of the most studied PLA2 members for its roles in the generation of AA and its subsequent 
signaling pathways [162].  cPLA2α possess a C2 domain that binds to intracellular Ca2+, leading 
to its translocation from the cytosol to both ER and Golgi membranes [163-164], where it 
regulates both Golgi structure and membrane trafficking. 
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Similar to the membrane tubulating activities of PAFAHIb, San Pietro et al. found that 
cPLA2α is capable of forming membrane tubules between Golgi cisternae [165], which provide 
direct continuities between cis, medial, and trans Golgi cisternae for anterograde intra-Golgi 
protein and membrane transport (Figure 1.3, Step 3) [20, 87-88].  These intra-cisternal 
membrane tubules are induced during times of rapidly increased secretory load [166], but it is 
unclear how stable they are and if they function under other conditions.  Indeed, the same study 
goes on to demonstrate that cells from cPLA2α knockout mice are still capable of transporting 
VSV from the ER through the Golgi complex to the plasma membrane but the protein becomes 
sequestered within the Golgi when PAFAHIb α1 is knocked down.  This clearly establishes 
redundancy of multiple PLA2 members in membrane trafficking.  However, it remains possible 
that cPLA2α may serve to provide distinct trafficking and sorting services than that of PAFAHIb, 
and this is demonstrated through experiments showing that cPLA2α is specifically involved in 
transport of transmembrane junction proteins such as VE-cadherin, occludin, and claudin-5 from 
the Golgi complex to cell-cell contacts [167].  Also, in Purkinje neurons, cPLA2α relies on Ca2+ 
influxes to translocate from the cytosol to the Golgi in order to regulate AMPA receptor levels at 
the plasma membrane [168].  Finally, other recent studies have provided evidence that cPLA2, in 
essence, negatively regulates COPI coated vesicle formation (Figure 1.3, Step 4), likely by 
shifting the balance toward membrane tubule formation (discussed further below) [54]. 
Overexpression of cPLA2α in kidney epithelial cells leads to fragmentation of the Golgi 
ribbon and prevents anterograde transport as protein cargo sequesters within the ER, while 
leaving the cytoskeletal and microtubule networks intact [169].  It is possible that membrane 
tubules formed by cPLA2α may serve as precursors to membrane vesicles and this claim is 
buttressed by observations that cholesterol-induced vesiculation of the Golgi membranes requires 
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cPLA2α recruitment to the Golgi and that this is inhibited by the cPLA2 inhibitor, methyl 
arachidonyl fluorophosphonate (MAFP) [170].  Interestingly, this same report goes on to show 
that this vesiculation is independent of clathrin coat complexes and requires dynamin 1 and 2, 
thus supporting the view that vesicles can possibly be pinched off of nascent membrane tubules.  
The activation of cPLA2α and its targeting to membranes have been extensively examined. 
cPLA2α can be activated through three distinct phosphorylation sites by PKC, MAPK family 
member ERK1/2, and CaM kinase, but the phosphorylation of cPLA2α does not always lead to 
AA release [171-173].  This observation clearly implicates cPLA2α to be involved in other 
processes that do not involve liberating AA and may also explain a possible route in uncoupling 
the functions of releasing AA from Golgi phospholipids and of regulating Golgi structure.  The 
relationship between phosphorylation and Ca2+-binding in regulating cPLA2α translocation to 
membranes remains unclear.  However, one report notes that AA can possibly mimic Ca2+ 
ionophores in stimulating cPLA2α translocation to ER but not Golgi membranes in a Ca2+-
independent manner [174].  The targeting of cPLA2α to Golgi membranes may be similar to 
PAFAHIb in that PIPs play a facilitative role.  Indeed, reports show that PI(4,5)P2 enhances both 
cPLA2α activity and membrane-binding affinity in vitro through interactions with cationic 
residues within the membrane-binding surface of the protein [175-176].  However, another study 
raises conflicting results by showing that PI(4,5)P2 only enhances cPLA2α activity and not its 
Ca2+-dependent membrane binding affinity [177].  Incidentally, Golgi membranes contain 
PI(4,5)P2 in addition to PI(4)P [178].   
Both membrane tubulation and vesiculation may be facilitated through enhanced 
membrane fluidity, and PLA2 activity may be involved in increasing membrane fluidity, as the 
addition of palmitoyl trifluoromethylketone (PACOCF3), a PLA2 inhibitor, reduces membrane 
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fluidity in rat hippocampal tissue [179-180].  Enhanced membrane fluidity may facilitate lateral 
segregation of conically shaped LPLs generated by PLA2 enzymes into regions of high curvature 
such as membrane tubules [181].  Membrane fluidity also facilitates the formation of lipid rafts 
as exemplified by the observation that PLA2 activity is specifically responsible for the budding 
and fission of liquid ordered (Lo) phase rafts from liquid disordered (Ld) giant unilamellar 
vesicles (GUVs) [182].  This is potentially explained by the hypothesis that PLA2 enzymes 
produce conically-shaped LPLs within Lo rafts, which in turn lead to the budding of rafts into 
membrane vesicles and/or tubules and is overall energetically favorable because the protrusion of 
Lo rafts into vesicles/tubules away from GUVs decrease the free energy that is confined within 
Lo/Ld phase boundary [182].  In another twist, lipid phases can additionally lead to inhibition of 
cPLA2α.  One study shows that although sphingomyelin (SPH) cannot be hydrolyzed by 
cPLA2α, Lo phases enriched in SPH can bind to and sequester cPLA2α from Ld phases that 
contain hydrolysable glycero-phospholipid substrates [183].  The same study showed that such 
inhibition is specifically due to sequestering cPLA2α within phases apart from substrate phases 
because the addition of cholesterol or ceramide leads to the abolishment of separated phases and 
the reestablishment of cPLA2α activity. 
 
1.7.3. PLA2G6/iPLA2-β 
A Group VIA-2 PLA2, PLA2G6/iPLA2-β (also known as iPLA2B, PNPLA9), is a third 
PLA2 member that regulates Golgi trafficking indirectly by regulating the ERGIC (Table) [33].  
The ERGIC is an independent compartment located between the ER and the cis-face of the Golgi 
complex, facilitates bidirectional trafficking between the two organelles, and may serve as a 
precursor to the cis aspect of the Golgi stack [184-185].  The ERGIC is comprised of 
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tubulovesicular membrane structures and potentially serves roles in cargo protein quality, 
sorting, and concentration [184]. PLA2G6/iPLA2-β has multiple splice variants, of which the full 
length variant, called L-iPLA2, is catalytically active while its shorter splice variants, ankyrin-
iPLA2-1 and -2 are inactive but thought to negatively regulate L-iPLA2 via forming oligomers 
through their ankyrin repeats [186-187].  PLA2 involvement at the ERGIC is first implicated 
through the use of PLA2 drug inhibitors that prevent the recycling of ERGIC-localized protein 
ERGIC-53 in addition to the formation of ERGIC membrane tubules [188].  Recent work shows 
that ARF1 and ARF4 knockdown can generate ERGIC membrane tubules that are dependent on 
PLA2G6/iPLA2-β as knockdown of this protein also leads to inhibition of membrane tubule 
formation [33].  The same study noted that PLA2G6/iPLA2-β-induced membrane tubules may be 
viable alternatives to vesicles in quickly and efficiently directing cargo between ERGIC clusters 
and cargo containing COPI vesicles (Figure 1.3, Step 5).  ERGIC tubulation and mobility are 
also regulated by microtubules and their associated motor proteins and whether these tubule-
inducing functions are independent or shared with PLA2G6/iPLA2-β remains unknown [189]. 
Aside from basic cell biological interest in understanding how phospholipid modifying 
enzymes and membrane tubules influence intracellular membrane trafficking, recent studies have 
revealed that the function of these enzymes and membrane structures might be linked to 
pathological conditions.  For example, mutations in human PLA2G6A gene (and in mouse 
models) cause a spectrum of autosomal recessive neurodegenerative disorders, characterized by 
severe cognitive and motor regression, now referred to as PLA2G6-Associated 
Neurodegeneration (PLAN) [190-193].  The connection between PLA2G6’s function at the 
ERGIC and disease manifestations in PLAN is not understood but could involve specific defects 
in secretory trafficking. 
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1.7.4. iPLA1γ 
The final cytoplasmic PLA protein that has effects on the Golgi complex is a PLA1 
family member, iPLA1γ (gene name DDH2 or KIAA0725p) (Table) [194-195].  The other two 
cytoplasmic PLA1 family members include iPLA1α (PA-PLA1) and iPLA1β (p125) [196].  While 
iPLA1γ shares a common characteristic with iPLA1β in that the overexpression of either results 
in structural disruption of both the ERGIC and the Golgi, only the overexpression of iPLA1γ lead 
to mislocalization of Golgi resident proteins such as p115 and GM130 [197].  One of the first 
iPLA1γ studies showed that the protein is localized to both Golgi and ERGIC membranes (Figure 
1.3) [194].  The same study indicated that siRNA knockdown of iPLA1γ disrupted COPI- and 
Rab6-independent, i.e., BFA stimulated, Golgi-to-ER retrograde trafficking, whereas VSVG-
ts045-GFP anterograde transport was unaffected.  However, a more recent study conflicts with 
these results, finding that iPLA1γ knockdown did not affect Golgi-to-ER retrograde trafficking 
but did inhibit VSVG-ts045-GFP anterograde transport [195].  These discrepancies can be 
explained by the observation that the original knockdown studies had an unintended off-target 
knockdown of Rab6 [195], which regulates Golgi retrograde trafficking [198].  In mammals, the 
physiological roles of the PLA1 family are unclear but it is known that iPLA1α is highly 
expressed in brain and testis and thus possibly linked to neural development and 
spermatogenesis, similar to PAFAHIb [159-160, 199-200].  In addition, the molecular 
mechanisms by which iPLA1γ influences trafficking through the Golgi complex are unknown. 
 
1.7.5. Lysophospholipid acyltransferases 
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The fruitful studies of PLA2 enzymes in Golgi membrane trafficking stimulated an 
interest in LPAT activity as a potential mediator of Golgi membrane trafficking, perhaps by 
counteracting the tubulating activity of PLA2 enzymes (Figure 1.4).  Given that in model 
membrane systems PLA2 and LPAT lipid products stabilize positive and negative curvature, 
respectively, and that PLA2 activity stimulates membrane tubulation in cells, it was hypothesized 
that LPAT activity might prevent tubule formation in cells [123].  It had also been hypothesized 
that the negative curvature at the neck of a budding vesicle could be stabilized by LPAT lipid 
products [201].  Finally, it was suggested that cytoplasmic PLA2 and LPAT enzymes could work 
in concert: cytoplasmic PLA2 enzymes could promote outward curvature or budding that would 
subsequently be acted on LPATs to produce negative curvature to facilitate coated vesicle 
production [123]. 
The first two reports of LPAT activity being involved in membrane trafficking were from 
studies of BARS and endophilin [202-204].  BARS is a mediator of Golgi membrane tubule 
fission [110], and endophilin is an N-BAR domain containing protein that was recently shown to 
be required for uncoating of coated vesicles at the plasma membrane but not fission per se [205]. 
 Both of these proteins were reported to have low levels of acyltransferase activity; however, this 
activity was later determined to be associated with LPAAT enzyme contaminants [206]. 
The first solid indication that LPATs were involved in membrane trafficking came from 
studies that utilized a powerful new tool, the small molecule CI-976.  CI-976 (2,2-methyl-N-
(2,4,6,-trimethoxyphenyl)dodecanamide) was originally synthesized as a fatty acid anilide 
derivative designed to mimic fatty acyl-CoA for inhibition of acyl-CoA:cholesterol 
acyltransferase (ACAT) [207-208].  It is a small hydrophobic, membrane permeant, and 
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Figure 1.4. Possible routes for the individual and concerted actions of PLA2 and LPAT 
enzymes to influence the formation of membrane tubules and coated vesicles. (A) 
Membrane tubules could be generated and regulated by the opposing actions of PLA2 and LPAT 
enzymes. Hydrolysis of membrane phospholipids by cytoplasmic PLA2 enzymes could generate 
positive curvature inducing LPLs, ultimately resulting in membrane tubule formation. The LPLs 
could be reacylated by LPAT enzymes back to phospholipids, thus negatively regulating the 
formation of membrane tubules. (B) The hydrolytic activity of cytoplasmic PLA2 enzymes could 
generate membrane tubules that are consumed through coated vesicle budding, which is 
facilitated by LPAAT activity for membrane fission. In this generic model, the coated vesicles 
could be either COPI vesicles budding from the ERGIC or AP-1 clathrin-coated vesicles budding 
from the TGN. The consequences of inhibition by PLA2 and LPAT antagonists are shown, which 
have been supported by several studies [31, 62]. 
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 competitive ACAT inhibitor [209].  While CI-976 possesses only weak inhibitor activity against 
ACAT, a screen for inhibition of Golgi associated LPAT activity showed strong inhibition of 
LPC and lysophosphatidylethanolamine (LPE) acyltransferase activities [210-213].  With this 
potent inhibitor, the study of LPAT enzymes in mammalian membrane trafficking immediately 
progressed.  Most intriguingly, treatment of mammalian cells with CI-976 stimulated a 
remarkable enhancement of Golgi membrane tubulation and retrograde trafficking [211-212].  
This tubulation activity was phenotypically similar to BFA induced tubulation, although 
comparatively delayed.  Additionally, CI-976-induced Golgi tubulation was inhibited by 
concomitant PLA2 inhibition, indicating for the first time that both PLA2 and LPATs work in 
concert to regulate the dynamic structure of the Golgi complex [212] 
Golgi-associated LPAT enzyme(s) could regulate membrane trafficking by one of, or a 
combination of, five mechanisms (Figures 1.4 and 1.5): 1) production of conical phospholipids 
that resist the high positive curvature present in tubules; 2) conversion of inverted-cone shaped 
LPLs that stabilize positive curvature to phospholipids that are less stabilizing; 3) production of 
conical phospholipids that stabilize the high negative curvature at the neck of budding vesicles; 
4) production of phospholipids that recruit vesicle-budding factors; and, 5) production of 
phospholipids that affect lipid and protein partitioning.  There is evidence for all of these 
mechanisms and deciphering the relative contribution of each is a major challenge in the field. 
Further studies identified a PC- and PE-forming LPAT tightly associated with the Golgi 
complex [210].  The connection between this enzyme and CI-976 stimulated tubulation of the 
Golgi complex and Golgi-to-ER retrograde trafficking is unclear [212], and the exact molecular 
identity of the LPC/LPEAT activity is still unknown.  In fact, recent studies strongly indicate that 
the observed CI-976 effect on the Golgi could be due to inhibition of LPAAT mediated acylation 
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of LPA to PA, which is catalyzed by AGPAT3/LPAAT3 (also called LPAATγ), a Golgi 
localized LPA specific acyltransferase (Table) [63].   
AGPAT3/LPAAT3 was the first specific LPAT shown to be involved in the dynamic 
function of the Golgi complex.  It is an integral membrane protein with two transmembrane 
domains and is found in both the Golgi complex and ER [214].  Overexpression of 
AGPAT3/LPAAT3 was shown to slow ERGIC-53 recycling from the cis-Golgi to the 
ER/ERGIC and to reduce BFA-stimulated membrane tubulation.  Conversely, 
AGPAT3/LPAAT3 knockdown accelerated ERGIC-53 recycling.  Importantly, overexpression 
of AGPAT3/LPAAT3 counteracted the tubule-inducing effects CI-976, suggesting that 
AGPAT3/LPAAT3 is a direct target of the drug.  However, this result does not rule out the 
possibility that the CI-976-inhibitable Golgi LPC/LPEAT activity also contributes to Golgi 
membrane remodeling.  For example, a Golgi LPC/LPEAT enzyme could come into play 
because AGPAT3/LPAAT3 generated PA can be hydrolyzed to DAG by PA phosphatase and 
then converted to PC or PE, followed by Lands Cycle remodeling via cPLA2α (Figure 1.7).  In 
addition, PC and PE can be generated via Golgi localized cholinephosphotransferase (CPT1) or a 
phosphoethanolamine transferase, respectively [215].  
Like PLA2 enzymes, LPATs are also involved in other secretory and endocytic 
trafficking steps.  For example, CI-976 reversibly inhibited a very late step in COPII vesicle 
budding, resulting in the accumulation of secretory cargo at ER exit sites (ERESs) [64].  
Interestingly, ERESs underwent Sar1p-dependent membrane tubulation in the presence of CI-
976, suggesting the involvement of LPAT activity in the fission of COPII budding elements in 
vivo.  In addition to secretory trafficking, CI-976 was also found to stimulate membrane tubules 
from endosomes and to inhibit recycling of transferrin and transferrin receptors from the 
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endocytic recycling compartment, suggesting a role for LPATs in the budding of vesicles from 
endosome tubules [211].  Currently, the precise LPATs involved in COPII budding or endocytic 
recycling have yet to be identified. 
 
1.8. Integration of cPLA2α and AGPAT3/LPAAT3 to Influence Golgi COPI Vesicle and 
Membrane Tubule Formation 
 
The above studies on Golgi-associated PLA2 and LPAT enzymes suggest an intimate 
association between the formation of membrane tubules and coated vesicles.  Support for this 
idea came from previous studies showing that CI-976 inhibited COPI vesicle formation [110].  
This association was recently directly tested by Hsu and colleagues who discovered that cPLA2α 
and AGPAT3/LPAAT3 function to regulate the relative abundance of COPI vesicle and 
membrane tubule formation (Figure 1.5) [54].  Using purified Golgi complex membranes in an in 
vitro COPI budding assay, they first found that COPI coatomer subunits and ARF1 are required 
for both vesicle and membrane tubule formation.  They surmised that ARF1 and coatomer 
initiates the budding events that become vesicles and membrane tubules.  When examining 
endogenous cPLA2α and AGPAT/LPAAT3 by immunofluorescence microscopy, they were 
shown to colocalize with endogenous coatomer proteins.  The coatomer subunit a-COP was 
shown by immuno-EM to localize to the base and tip, but not the stem, of membrane tubules.  In 
this assay, AGPAT3/LPAAT3 activity increased COPI vesicle formation, which was shown by 
the addition of CI-976 or AGPAT3/LPAAT3 antibody to budding reactions.  The authors suspect 
that AGPAT3/LPAAT3-generated PA, a known recruiter of COPI coatomer subunits and BARS, 
a COPI vesicle fission protein [110], as well as a negative curve-inducing phospholipid [59, 
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216], are responsible for stimulating COPI coating of the nascent vesicle.  In support of this idea, 
inhibition of AGPAT3/LPAAT3, by CI-976 or specific antibody, stimulated membrane 
tubulation at the expense of vesicle production.  The final step of COPI vesicle fission required 
the conversion of PC to PA by PLD2, but not PLD1.  
 The addition of pharmacological PLA2 inhibitors or anti-cPLA2α antibody to cytosol in 
their reconstitution assay increased vesicle formation and concomitantly decreased tubule 
formation, which was reversed by the addition of purified cPLA2α.  Their model posits that 
ARF1 and COPI coatomer recruitment initiates bud formation and that buds then mature into 
either vesicles or membrane tubules, depending on the balance of cPLA2α and 
AGPAT3/LPAAT3 activity (Figure 1.3: Step 5, Figure 1.5B-E).  It is still a matter of debate as to 
whether generation of curve-inducing PA or recruitment of effector proteins, is most important in 
AGPAT3/LPAAT3-mediated vesicle biogenesis.  They further suggest that AGPAT3/LPAAT3 
generated PA initiates negative membrane curvature but is insufficient for complete vesicle 
budding, a process that is finalized by the additional generation of PA by PLD2 (Figure 1.5F).  
The generation of PA by both enzymes could aid in the recruitment of the fission protein BARS 
[110].  Hsu and colleagues also assert that the biogenesis of Golgi membrane tubules, both 
intercisternal and intracisternal, which facilitate anterograde trafficking and Golgi ribbon 
formation respectively, are initiated as COPI buds (Figure 1.5D).  These results provide 
important insights into how Lands cycle phospholipid remodeling might influence the dynamic 
behavior of Golgi membranes.  Interestingly, however, this model of membrane curvature 
initiation solely by COPI/ARFs cannot explain enhanced Golgi membrane tubule formation by 
BFA or knockdown of ARF GEFs, and underscores the notion that cytoplasmic PLA2 enzymes 
can induce membrane tubules on their own (Figure 1.5G).  In addition, because COPI vesicle  
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Figure 1.5. Models for cPLA2α and AGPAT3/LPAAT3 activities contributing to COPI 
vesicle and Golgi membrane tubule formation.  (A) Flat membrane that will be modified by 
curve producing proteins; (B) Arf1 and coatomer binding deforms membranes, initiating the first 
steps of vesiculation or tubulation; (B to C) AGPAT3/LPAAT3 activity produces unsaturated 
PA, a lipid that resists positive curvature; (B to D) cPLA2α activity produces LPC, a positive 
curvature stabilizing and tubule inducing lipid; (C to E) LPC stabilizes positive curvature of the 
bud and unsaturated PA stabilizes negative curvature at the bud neck; (F) The concerted PA 
production activities of AGPAT3/LPAAT3 and PLD2 at the bud neck help to recruit BARS and 
aide vesicle fission; (G) PLA2 activity can induce membrane curvature and tubulation in the 
absence of coatomer.   
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Figure 1.6. Model integrating membrane curvature produced by PLA2 activity and 
transport along microtubules.  Cytoplasmic PLA2 activity, perhaps that of PAFAHIb, aids in 
the formation of membrane tubules from the TGN in conjunction with kinesin and microtubules 
for transport to the plasma membrane (PM) (top membrane tubule). In addition, PAFAHIb α1 
and α2 initiate outward membrane curvature to generate a membrane tubule (middle short 
membrane tubule), which can subsequently be pulled/extended along microtubules (MT) by Lis1 
and Ndel interactions with dynein (bottom longer membrane tubule). These concerted activities 
may be able to carry the membrane tubule towards the minus end of microtubules, thus 
facilitating the coalescence of Golgi stacks near the centrosome.  Adapted from Yamada et al., 
2008. 
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budding and fission can be reconstituted using minimal components coatomer and ARF-GTP 
[107], these phospholipid modifying enzymes likely function to enhance the efficiency of the 
COPI budding machinery. 
The central roles of DAG and PA in Golgi membrane tubule and vesicle formation have 
been extensively examined, and their participation raises important points for the analysis of how 
lipid/phospholipid changes affect membrane trafficking.  Both DAG and PA have been shown to 
be required for membrane tubule and vesicle formation from the Golgi and TGN [116, 217-220], 
likely by generating both curvature-altering phospholipids and platforms for effector protein 
binding.  How the Golgi complex controls the numerous pathways that lead to and from PA and 
DAG is still a mystery (Figure 1.7).  In addition, understanding how lipids/phospholipids can 
exert dramatic local effects in the face of rapid lateral diffusion and conversion to other products 
is a challenge.  Nevertheless, it is becoming increasingly clear that remodeling of Golgi 
membrane phospholipids by PLA2 and LPAT enzymes adds a new layer of complexity to an 
already complex organelle.  Moreover, it is likely that the full complement of PLA and LPAT 
enzymes involved in secretory (and endocytic) trafficking has not yet been revealed. 
 
1.9. Conclusions and future directions 
 
Although the past decade of research revealed detailed information on the many facets of 
membrane trafficking, especially in coated vesicles, there is little information on how 
physiological stimuli such as growth factors, stress, and increased secretory loads can lead to 
signaling that subsequently affects membrane tubulation.  Although membrane tubules and 
vesicles may work in a concerted manner, more studies are needed to delineate the importance of  
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Fig. 1.7. Enzymatic pathways, several involved in Lands cycle reactions, which lead to the 
modification and interconversion of lipid species.  Lysophosphatidic acid (LPA); phosphatidic 
acid (PA); diacylglycerol (DAG); phosphatidylcholine (PC); lysophosphatidylcholine (LPC); 
sphingomyelin (SM); ceramide (Cer); phosphatidylinositol 4-phosphate (PI4P); 
phosphatidylinositol 4, 5-phosphate (PI4,5P); 1-acylglycerol-3-phosphate acyltransferase 3 
(AGPAT3); lysophosphatidic acid acyltransferase 3 (LPAAT3); phospholipase A2 (PLA2); 
diacylglycerol kinase (DAGK); phosphatidic acid phosphatase (PA P'tase); phospholipase D 
(PLD); PC specific phospholipase C (PC-PLC); phosphatidylinositol specific PLC (PIPLC); 
sphingomyelin synthase (SMS). 
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membrane tubules from membrane vesicles and to determine any unique roles for membrane 
tubules.  It remains unclear whether membrane tubules actually possess different compositions of 
membrane-bound or soluble protein cargo when compared to membrane vesicles.  It is also 
unknown whether membrane tubules have any advantages in efficiency when compared to 
membrane vesicles, although studies have suggested that tubule-based continuities within Golgi 
cisternae provide efficient means of transporting soluble and membrane cargo [2, 37].  As 
membrane tubules and vesicles may work cooperatively, studying one aspect without disrupting 
the other may be the most difficult obstacle to overcome.  Further understanding membrane 
tubule biology will not only advance the field of membrane trafficking but may also uncover 
novel physiological functions with translational significance.  Despite the wealth of information 
on numerous enzymes partaking in membrane tubulation, there is relatively little information on 
the temporal and spatial regulation in producing the proper amounts of membrane tubules.  This 
study seeks to address this problem by identifying novel regulators of membrane tubulation, thus 
shedding light on its regulation. 
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CHAPTER 2 
 
Global Kinome Analysis Reveals PACE1 as a  
Novel Regulator of Golgi Membrane Tubulation 
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2.1. Abstract 
  
Membrane tubules play important roles in numerous processes ranging from Golgi 
structural maintenance to membrane trafficking.  Previous studies have identified important 
players in membrane tubulation, including lipid-remodeling enzymes such as PLAs and LPATs.  
However, it remains unclear how these lipid-remodeling enzymes or other proteins with 
membrane tubulating abilities can be regulated during physiological changes such as increased 
secretory loads or growth stimuli.  Kinases are known regulators of both protein function and 
signal transduction and are thus likely suspects in regulating membrane tubule biogenesis.  The 
present study analyzes the entire library of known and predicted human kinases, or the kinome, 
within the context of a screen designed to detect potential regulators of BFA-induced Golgi 
tubulation in HeLa cells.  We then focused on further characterizing one inhibitory hit, PACE1 
(Protein-Associating with the Carboxyl-terminal domain of Ezrin), in determining its roles in 
Golgi membrane tubulation and function.  PACE1 co-localized with Golgi resident proteins such 
as galactosyltransferase tagged with GFP (GalT-GFP), mannosidase-II (ManII), GPP130, and the 
TGN protein, mannose6-phosphate receptor (M6PR).  Knockdown of PACE1 inhibited BFA-
induced Golgi tubulation, Golgi structural maintenance, Golgi ribbon reformation, and 
anterograde trafficking of both soluble and transmembrane protein cargo.  All of these 
phenotypes were reversed upon overexpression with an RNAi-resistant construct of PACE 
tagged with myc (PACE1-myc).  We conclude that PACE1 plays important roles in membrane 
tubulation at the Golgi and that these membrane tubules participate in a variety of physiological 
functions.  The results of this study should help pave the way in understanding both existing and 
novel mechanisms behind membrane tubulation at the Golgi complex. 
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2.2. Introduction 
 
The functional aspects and biochemical mechanisms of membrane tubules are being unraveled as 
numerous reports link them to roles in membrane trafficking [1].  A fundamental step in forming 
membrane tubules includes the formation of membrane curvature via three primary mechanisms, 
including changes to lipids within membrane leaflets, insertion of proteins into one leaflet, and 
the formation of protein scaffolds alongside membranes [2].  The importance of lipid changes 
within membranes is exemplified by the discovery that numerous cytoplasmic phospholipases 
play roles in inducing membrane tubulation to facilitate trafficking events, possibly by altering 
the physical structures of lipids in single leaflets of a membrane bilayer to induce membrane 
curvature, and thus membrane tubules [3].  For example, the phospholipase A2 (PLA2) enzymes 
can alter phospholipid (PL) shapes by virtue of cleaving acyl chains from sn-2 positions of PLs 
to spawn membrane tubules that facilitate membrane trafficking and structural homeostasis at the 
Golgi [4-5].  Interestingly, modulation of PL shapes can also be catalyzed by lysophospholipid 
acyltransferases (LPATs) that carry out the reverse reaction of PLA2s by transferring fatty acids 
onto lysophospholipids (LPLs), which subsequently contributes to trafficking and Golgi 
homeostasis [6-7].  The roles of lipid-modifying enzymes in membrane tubules are not limited 
within Golgi membranes as other studies show evidence that phospholipases also induce 
membrane tubules among endosomes and the ER-Golgi intermediate compartment (ERGIC) [8-
9].  Despite the wealth of information on numerous enzymes partaking in membrane tubulation, 
relatively little is known about how these proteins are temporally or spatially regulated to 
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produce the proper amounts of membrane tubules.  Furthermore, novel proteins may exist to 
induce membrane tubules. 
 
2.3. Results 
 
2.3.1. siRNA screen for proteins that regulate membrane tubulation 
 Golgi membrane tubules are both ephemeral and highly dynamic, making them difficult 
to image at steady-state levels.  Fortunately, BFA possesses two important characteristics in 
serving as an excellent model system for studying membrane tubule biogenesis.  First, it induces 
abundant amounts of Golgi membrane tubules within several minutes in a reversible manner.  
Secondly, BFA-induced Golgi membrane tubulation ultimately results in the fusion of all Golgi 
cisternal membranes into the ER, resulting in complete loss of the traditionally compact, 
juxtanuclear Golgi structure.  We exploited this second property of BFA to identify novel protein 
regulators of Golgi membrane tubulation.  We hypothesized that protein inhibitors of BFA-
induced membrane tubulation will slow down the loss of compact, juxtanuclear Golgi structures 
while protein-activators will hasten the loss of compact, juxtanuclear Golgi structures.   
We utilized an siRNA library targeting all of the known human kinases, along with 
known pseudo-kinases and scaffold proteins, in a high-throughput, functional screen that 
analyzed the loss of compact, juxtanuclear Golgi structures upon treatment with BFA.  HeLa 
cells stably expressing GFP-tagged galactosyltransferase (GalT-GFP), a resident of trans Golgi 
cisternae, were incubated in 96-well plates with siRNAs or controls and then treated with BFA to 
induce rapid tubule-mediated, retrograde transport of Golgi membranes to the ER.  During this 
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process, the average GalT-GFP fluorescence per area significantly dims, as the ER possesses a 
surface area that is five-fold larger than that of the Golgi complex [10-11].  We then utilized 
automated image analysis software to quantify the loss of bright, juxtanuclear Golgi signal 
following BFA treatment (Figure 2.2).  BFA treatment (5 μg/ml) leads to complete loss of 
compact, juxtanuclear Golgi structures within 20 minutes under the conditions of this assay 
(Figure 2.1A).   
The siRNA library (Ambion) targets 719 gene products via three separate, unique siRNA 
oligos per gene.  Utilizing 96-well plates, HeLa/GalT-GFP cells were first plated and then 
transfected with either 30 nM siRNA or water as negative controls.  After 24 h, cells were treated 
with BFA (5 μg/ml for 10 min).  Nuclei were stained with Hoechst and then imaged and 
quantitated via automation.  Analysis software quantitated intact Golgi structures as determined 
by average GalT-GFP fluorescence per area exceeding an arbitrary threshold.  The entire library 
was screened three independent times and the results were averaged, with potential screen hits 
determined as those that exceed a 20% threshold difference in GalT-GFP fluorescence when 
compared to untransfected, untreated cells.  Since three separate siRNA oligos were available 
against each gene, potential screen hits were not necessarily ruled out in the case that only one 
siRNA exhibited a strong phenotype while the others did not.  Among the 719 targeted genes 
within the library, 93 were identified as potential regulators of BFA-induced Golgi tubulation 
(Figure 2.1B).  The majority of the hits comprise genes involved in lipid modification, cell cycle 
regulation, or have other/unknown functions, while a small portion of the hits are linked to 
membrane trafficking or the cytoskeleton (Figure 2.1C).  Among these results, PACE1 (Protein-
Associating with the Carboxyl-terminal domain of Ezrin) was identified as a potential hit, with a 
25% inhibition of BFA-induced Golgi tubulation.  Of the three siRNAs targeting PACE1, one  
66 
 
 
 
 
Figure 2.1.  PACE1 knockdown inhibits BFA-induced Golgi dispersal.  (A) HeLa cells stably 
expressing the trans-Golgi marker GalT-GFP undergo Golgi dispersal after 20’ of 1 μg/ml BFA 
treatment and can be quantified via integrated granular intensity.  Error bars represent SEM of 
n=3.  (B) 726 human kinases were knocked down with 3 distinct siRNA oligos and their effects 
on BFA-induced Golgi dispersal were graphed as averaged values for each kinase target.  ~12% 
kinase targets exceed an arbitrary threshold of 20% inhibition (dotted vertical line) relative to 
untransfected control cells.  (C) Categorization of hits above the threshold.  (D) Averaged 
quantitation of each PACE1 siRNA oligo on BFA-induced Golgi dispersal.  Error bars indicate 
SEM of n=3.  Bar graphs represent mean values. 
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Figure 2.2.  Potential hits inhibit BFA-induced Golgi dispersal.  HeLa cells stably expressing 
the trans-Golgi marker GalT-GFP and stained for nuclei via Hoechst (blue) underwent Golgi 
dispersal upon BFA treatment (1 μg/ml) after 10’.  Hits that inhibited this process yielded cells 
with intact, juxtanuclear structures while non-hits leave BFA effects intact, permitting intact, 
juxtanuclear Golgi structures to become absorbed into a dispersed, ER-like structure.  Scale bar 
represents 10 μm. 
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siRNA alone inhibited BFA-induced Golgi tubulation by 49% ± 14% standard error of the mean 
(SEM) when compared to untransfected control (Figure 2.1D).  Western analysis of whole cell 
HeLa lysates showed that a similar siRNA, but not from the library, reduced endogenous PACE1 
protein levels in vivo by >95% (Figure 2.3A).  Furthermore, this siRNA also reduced 
overexpressed, myc-tagged PACE1 levels by >90%, whereas rescue with a PACE1-myc 
construct, harboring two silent mutations to confer RNAi-resistance, completely restored 
PACE1-myc protein levels (Figure 2.3B).   
PACE1 is also known as Scy1-like 3 (Scyl3) and is a member of the Scy1-like (Scyl) 
family of purported kinases.  All three members of the Scyl family possess a conserved 
serine/threonine kinase domain along with HEAT domain repeats (Figure 2.4).  Scy1 itself is a 
yeast protein with unknown functions.  PACE1 is a ubiquitously expressed 742-residue protein 
that was originally indentified in a yeast 2-hybrid screen as an interacting protein with the C-
terminal domain of Ezrin [12].  Ezrin is a member of the ERM (Ezrin, Radixin, Moesin) family 
that is involved in both facilitating interactions between the cytoplasmic domains of 
transmembrane proteins with filamentous actin and coordinating signal transduction from the 
plasma membrane into the cytoplasm [13-14].  The lone study that identified PACE1 revealed 
that the protein localizes to both the Golgi complex and plasma membrane ruffles, with N-
terminal myristoylation required for localization to the former [12].  Additionally, the same study 
reported that PACE1 does not actually possess any true kinase activity, suggesting that it is a 
pseudo-kinase.  Although PACE1’s functions remain unknown, studies have implicated its two 
family members as important players vesicle-mediated membrane trafficking.  For example, 
several studies provided evidence that Scyl1 regulates both Golgi morphology and COPI-
mediated  retrograde  trafficking  [15-16].  Scyl2,  also  known  as  CVAK104  (coated vesicle- 
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Figure 2.3.  PACE1 knockdown reduces both endogenous PACE1 and transiently 
expressed PACE1-myc and can be rescued with an RNAi-resistant construct.  (A) Western 
blot of HeLa cell lysates that have been transiently transfected with siRNA against control or 
PACE1 and then probed with anti-PACE1 antibody.  Protein levels were quantified and 
normalized to α-tubulin expression levels.  (B) HeLa cells were transfected with siRNA against 
either control or PACE1 and were additionally transfected with PACE1-myc or an RNAi-
resistant construct, PACE1-mycR.  Whole cell lysates were then analyzed via Western blotting 
and probed with anti-myc and anti-α-tubulin antibodies.  ** and *** denote two-tailed P-value of 
<0.01 and <0.001, respectively, for n=3.  Error bars indicate SEM of n=3.  All bar graphs display 
mean values. 
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Figure 2.4.  Scyl family members and their known protein domains.  S/T kinase: 
serine/threonine kinase domain.  C-C: coiled-coil domain. 
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associated kinase of 104 kDa), has been reported to actually possess kinase activity and is 
capable of regulating the β2-adaptin subunit of the AP-2 clathrin adaptor protein [17].  Scyl2 has 
also been linked to AP-1 and the regulation of clathrin-mediated SNARE sorting [18].  
Furthermore, Scyl2 also strongly associated with the Golgi complex and can regulate trafficking 
between the TGN and the endosomal system [19]. 
 
2.3.2. PACE1 co-localizes with Golgi membrane markers 
PACE1 has previously been observed to co-localize with the trans-Golgi resident protein, 
Golgin-97, in addition to plasma membrane ruffles within MCF-7 human breast cancer cells  
[12].  In HeLa cells, endogenous PACE1 immunofluorescence co-localized with GPP130, a cis-
Golgi marker but very little was seen in the cell cortex (Figure 2.5A).  HeLa cells overexpressing 
PACE1-myc show that the protein, as determined via anti-myc antibodies, co-localized with 
GPP130, a cis-Golgi marker, Mannosidase-II (Man II), a medial-Golgi marker, and partially co-
localized with mannose6-phosphate receptor (M6PR), a trans-Golgi network (TGN) marker, and 
with membrane ruffles (Figure 2.5B). 
 
2.3.3. PACE1 knockdown disrupts BFA-induced Golgi tubulation 
After confirming that PACE1 localized to the Golgi complex, we next analyzed whether 
knockdown of endogenous PACE1 disrupts BFA-induced Golgi tubulation and its subsequent 
retrograde trafficking into the ER.  HeLa/GalT-GFP cells were first transfected with either 
siRNA against PACE1 or scrambled siRNA as a negative control.  After 24 h, cells were treated 
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with BFA for various periods of time.  These experiments confirmed the siRNA screen results 
and further demonstrated that PACE1 knockdown significantly reduced the rate of BFA-induced 
Golgi loss (Figure 2.6A).  To directly determine if PACE1 knockdown inhibits Golgi membrane 
tubule formation, we counted the number of cells with tubulated Golgi membranes.  The results 
showed that PACE1 knockdown reduced membrane tubule formation by ~43% (Figure 2.6B).  
To show that these phenotypes are not due to off-target defects, a PACE1-myc fusion expression 
construct, which harbors two silent mutations to confer siRNA resistance, lead to a significant 
rescue of knockdown phenotypes by restoring intact Golgi structures and BFA-induced Golgi 
membrane tubules to more closely resemble control levels (Figure 2.7A & 2.7B). 
 
2.3.4. PACE1 knockdown disrupts Golgi reformation after BFA washout 
The effects of BFA have long been known to be reversible, which has been used as a 
model system for biogenesis of the Golgi complex [20].  After washing out BFA from cells, the 
Golgi undergoes the reformation of separate mini-stacks, which appear as punctate staining 
within the juxtanuclear region [21].  These mini-stacks then coalesce into an intact Golgi ribbon 
via PLA2-dependent membrane tubules [22].  We thus sought to determine whether PACE1 may 
facilitate this step in forming Golgi membrane tubules from Golgi mini-stacks to restore an intact 
ribbon structure.  HeLa/GalT-GFP cells were first transfected with either siRNA against PACE1 
or a scrambled siRNA as a negative control.  The next day, cells were treated with BFA (1 
μg/ml) for 20 minutes to completely disperse the Golgi complex, and then subsequently washed 
free of the drug to permit Golgi reformation.  PACE1 knockdown led to a significant disruption 
of Golgi ribbon reformation from mini-stacks, and this was most pronounced within 90 minutes  
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Figure 2.5.  PACE1-myc co-localizes with Golgi markers.  (A)  HeLa cells incubated with 
antibodies against endogenous PACE1 and cis-Golgi marker.  (B)  HeLa cells transiently 
transfected with PACE1-myc and then probed with antibodies against myc epitope along with 
Golgi markers such as cis-Golgi marker GPP130, medial-Golgi marker mannosidase-II (ManII), 
and trans-Golgi network (TGN) marker mannose6-phosphate receptor (M6PR).  Scale bar 
represents 10 μm. 
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Figure 2.6.  PACE1 knockdown delays Golgi dispersal and tubulation.  HeLa cells stably 
expressing GalT-GFP were transfected with siRNA against control or PACE1 for 18 h and then 
treated with 1 μg/ml BFA over 9’ and then quantitated for (A) loss of intact Golgi structures or 
(B) percentage of cells possessing tubulated Golgi structures (displaying >3 Golgi membrane 
tubules spanning the length of the Golgi).  Two-tailed P-values of <0.01 for n=3 denoted by **.  
Error bars indicate SEM of n=3. 
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Figure 2.7.  PACE1 rescue restores BFA-induced Golgi dispersal and tubulation.  HeLa 
cells stably expressing GalT-GFP were transfected with siRNA against control or PACE1 along 
with empty pcDNA vector (control) or RNAi-resistant PACE1 (PACE1-mycR) for 18 h.  Cells 
were then treated with 1 μg/ml BFA over 9 min and then quantitated for (A) loss of intact Golgi 
structures or (B) percentage of cells possessing tubulated Golgi structures (displaying >3 Golgi 
membrane tubules spanning the length of the Golgi).  Two-tailed P-values of <0.01 for n=3 
denoted by **.  Error bars indicate SEM of n=3. 
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(Figure 2.8A).  Live-cell imaging revealed that PACE1 knockdown cells failed to reform intact 
Golgi ribbon upon BFA washout, when compared to control cells (Figure 2.8C).  In control cells, 
about 13% ± 2% (SEM) possessed fragmented Golgi structures while PACE1 knockdown cells 
possessed about 84% ± 4% (SEM) fragmented Golgi structures (Figure 2.8B).   
 
2.3.5. PACE1 knockdown fragments the Golgi 
Membrane tubules are not only important for reformation of Golgi ribbon structures from 
mini-stacks but are also thought to be vital in the homeostatic maintenance of intercisternal Golgi 
connections [23].  For example, knocking down cytoplasmic PLA2 enzymes that mediate Golgi 
tubule formation eventually leads to Golgi fragmentation into puncta-like mini-stacks [4-5].  
Thus, we examined whether knocking down PACE1 disrupts maintenance of intact Golgi 
ribbons, leading to Golgi fragmentation.  When HeLa cells were transfected with scrambled 
RNA as control, about 14% ± 2% (SEM) displayed a fragmented Golgi phenotype, characterized 
by possessing greater than 3 separate Golgi fragments (Figure 2.9).  In contrast, cells transfected 
with PACE1 RNA resulted in a significant increase to 37% ± 5% (SEM) of cells harboring 
fragmented Golgi structures. 
The fragmented Golgi ribbon appeared to be mini-stacks as each punctate-like structure 
contains Golgi markers such as GalT-GFP, a trans-Golgi marker, GPP130, a cis-Golgi marker, 
mannosidase-II (ManII), a medial-Golgi marker, and M6PR, a TGN marker (Figure 2.10).  Golgi 
fragmentation has been previously linked to defects in cytoskeletal components, including 
microtubules, filamentous actin, and both microtubule- and actin-based motor complexes [24-
27].  However, in PACE1 knockdown cells, both microtubule and actin cytoskeletal networks 
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largely appeared unaffected when compared to control cells (Figure 2.10) Furthermore, Golgi 
fragmentation induced by PACE1 knockdown did not appear to affect the localization of coat 
proteins such as β-COP or clathrin AP-1 adaptors from localization to Golgi mini-stacks, despite 
the Golgi undergoing significant fragmentation (Figure 2.10). 
 
2.3.6. PACE1 knockdown disrupts membrane trafficking 
Membrane tubules not only connect the Golgi complex together for structural integrity 
but are also important for anterograde and retrograde trafficking of protein-membrane cargo and 
in certain contexts, intercisternal tubules increase in abundance in response to secretory loads 
entering the Golgi complex [4-5, 23].  Therefore, we examined whether knocking down PACE1 
leads to any phenotypic changes in anterograde trafficking of both soluble (secretory horseradish 
peroxidase, ssHRP) and membrane-bound (VSV-G) cargo.  HeLa cells transfected with a 
scrambled control siRNA yielded a ssHRP secretion rate of 0.29 (A.U./h), while in contrast, 
PACE1 knockdown cells yielded a rate of 0.10 (A.U./h), which is ~65% slower (Figure 2.11A).  
Rescue of PACE with an RNAi-resistant PACE1-myc construct restored ssHRP secretion to 
control levels (Figure 2.11B). 
Interestingly, transmembrane protein cargo may undergo anterograde trafficking via 
distinct mechanisms and routes than those of soluble cargo [28-29], and thus PACE1 knockdown 
could have differential effects on secretion.  In addressing this possibility, an overexpression 
construct harboring the temperature-sensitive transmembrane protein, VSVG-tsO45-YFP, was 
transfected into HeLa cells.  At 40ºC, VSVG-tsO45-YFP reversibly misfolds, leading to its 
sequestration within the ER.  When shifted to 20ºC, it is able to correctly fold and traffick out of  
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Figure 2.8.  PACE1 knockdown prevents Golgi ribbon reformation.  (A) HeLa cells stably 
expressing GalT-GFP were knocked down with either control or PACE1 siRNA, treated with 
BFA at 1 μg/ml for 20’, washed of drugs, and then permitted to undergo Golgi ribbon recovery 
for 90’.  Scale bar represents 10 μm.  (B) Cells were quantitated for possessing fragmented Golgi 
structures (>4 Golgi fragments.  Two-tailed P-value of <0.001 for n=3 is denoted by ***.  Error 
bars indicate SEM of n=3.  (C) Live-cell imaging of HeLa cells stably expressing GalT-GFP 
were treated with BFA as in (A) but then washed free of drug and permitted to recover in serum 
medium over 90’ at 37ºC.  Scale bar represents 10 μm. 
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Figure 2.9.  PACE1 knockdown leads to Golgi fragmentation.  HeLa cells stably expressing 
GalT-GFP were knocked down with either control or PACE1 siRNA and quantitated for 
fragmented Golgi structures (>4 Golgi fragments).  Two-tailed P-values of <0.05 or >0.05 are 
denoted by * or ‘ns’, respectively.  Error bars indicate SEM of n=3.   
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Figure 2.10.  Golgi fragments by PACE1 knockdown co-localize with Golgi markers.  HeLa 
cells stably expressing trans-Golgi marker, GalT-GFP, where transiently transfected with siRNA 
against either control or PACE1.  Cells were then labeled via immunofluorescence against Golgi 
markers, including cis-Golgi GPP130, medial-Golgi mannosidase-II (ManII), along with 
coatomer protein β-COP and cytoskeletal components α-tubulin and filamentous actin (F-actin).  
Scale bar represents 10 μm. 
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Figure 2.11.  PACE1 knockdown disrupts ssHRP secretion.  (A) HeLa cells knocked down 
with either control or PACE1 siRNA were transfected with ssHRP-FLAG and then assayed for 
ssHRP-FLAG secretion into the media.  Equations represent simple linear regressions fitted to 
the data, with the y intercept set to zero.  Two-tailed P-values of <0.01 and <0.001 are denoted 
by ** and ***, respectively.  Error bars indicate SEM of n=3.  (B) The same experiment was 
done along with rescue with empty pcDNA3 vector (control) or RNAi-resistant PACE1-myc.   
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the ER until it is blocked within the TGN, where a final temperature shift towards 32ºC leads to 
its eventual trafficking onto the plasma membrane (PM) in a synchronous fashion [30-31].  
VSVG-ts045-YFP on the PM can be quantified via antibodies that specifically recognize 
extracellular epitopes of VSVG-ts045-YFP without having to permeablize the cells.  While no 
surface VSVG-ts045-YFP is visible prior to a temperature shift to 32ºC, an abundant amount of 
ectopic VSVG-ts045-YFP can be detected 45 minutes after temperature shift (Figure 2.12).  
Knocking down PACE1 significantly reduced VSVG-ts045-YFP trafficking to the plasma 
membrane, rendering a conspicuously visible amount of the protein still present within the TGN 
when compared to control cells (Figure 2.13A).  Using this system, cells transfected with control 
siRNA were able to transport VSVG-ts045-YFP to the PM at a rate of ~9.3 (A.U./15 min) while 
cells transfected with PACE1 siRNA yielded a rate of ~5.3 (A.U./15 min) of VSVG-ts045-YFP 
onto the PM, which is ~ 43% less than that of control cells (Figure 2.13B). 
 
2.4. Discussion 
Here we describe an siRNA screen of the human kinome in a high-throughput assay to 
identify regulators of Golgi membrane tubule formation and function.  The screen utilized BFA 
because it is a potent inducer of membrane tubulation in mammalian cells, and we reasoned that 
proteins which influence BFA-stimulated tubule formation would also function at the Golgi 
under normal circumstances.  Indeed, this approach was validated by finding that several 
proteins identified in this way, e.g., PACE1, help regulate the functional organization of the 
Golgi complex.   
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Figure 2.12.  PACE1 knockdown disrupts VSVG-YFP trafficking.  HeLa cells knocked 
down with either control or PACE1 siRNA were transfected with VSV -YFP and after 1.5 h of 
temperature block at 19.5ºC to accumulate VSVG-YFP at the TGN, cells were shifted to 32ºC to 
permit VSVG-YFP to traffic from the TGN to the plasma membrane.  Surface VSVG was 
detected via anti-VSVG antibodies over non-permeablized cells.  Scale bar represents 10 μm. 
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Figure 2.13.  PACE1 decreases VSVG-YFP secretion kinetics.  HeLa cells knocked down 
with either control or PACE1 siRNA were transfected with VSV -YFP and after 1.5 h of 
temperature block at 19.5ºC to accumulate VSVG-YFP at the TGN, cells were shifted to 32ºC to 
permit VSVG-YFP to traffic from the TGN to the plasma membrane.  Surface VSVG was 
detected via anti-VSVG antibodies over non-permeablized cells.  (A) The ratios of fluorescent 
intensities of surface VSVG-YFP to total VSVG-YFP were quantitated and a simple linear 
regression was fitted to the data.  Two-tailed P values within timepoints of <0.05, <0.01, and 
<0.001 are denoted by *, **, and ***, respectively.  Error bars indicate SEM of n=3.  (B) Same 
as (B) but with rescue via empty pcDNA3 vector (control) or RNAi-resistant PACE1-myc. 
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Although PACE1 was initially identified as a binding partner of ezrin, our results clearly 
show that its loss by siRNA knockdown results in several structural and functional changes to 
the Golgi complex.  Whether PACE1 serves as a modulator or direct mediator of Golgi 
membrane tubulation is unclear.  Our results showed that knocking down PACE1 does not 
completely block Golgi membrane tubulation, which supports the idea that PACE1 can serve as 
a modulator of Golgi membrane tubulation.  However, it is possible that, although siRNA-
mediated knockdown reduced PACE1 levels by ~90%, the remaining PACE1 is sufficient to 
mediate some Golgi function.   
Interestingly, PACE1’s other family members appear to play important but not widely 
recognized roles in Golgi function.  Scyl2/CVAK104 was originally found to be a kinase 
associated with plasma membrane AP-2 clathrin-coated vesicles [17]; however, recent studies 
demonstrated that Scyl2/CVAK104 binds to clathrin at the TGN and contributes to AP-1 
clathrin-coated vesicle formation for M6PR-mediated delivery of newly synthesized lysosomal 
enzymes to lysosomes [18-19].  In contrast, Scyl1 was recently shown to be required for COPI-
dependent retrograde trafficking from the Golgi complex to the ER [16].  The molecular 
mechanisms by which PACE1 regulates Golgi structure and function are unknown, but given the 
functions of other family members, PACE1 may have some influence on coated vesicle 
formation.  Additional studies will be required to dissect its specific role. 
PACE1 itself may be regulated, and while little is known about the protein, it has been 
identified in two separate ubiquitinome studies to be the only member of the Scyl family to be 
ubiquitinated [32-33].  Its physiological roles would be fascinating to pursue, as its family 
member, Scyl1, was previously linked with neurodegenerative disorders in mice harboring loss-
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of-function mutations in the protein [34].  Interestingly, the functions of Scyl1 are not completely 
confined within the Golgi, as it has been reported that Scyl1 is also involved in nuclear tRNA 
export as a regulator at the nuclear pore complex, which raises a possibility that Scyl family 
members may have diverse functions across multiple organelles [35].  Roles in nuclear transport 
may not be too surprising, considering that both Scyl1 and PACE1 possess HEAT domain 
repeats, which have been previously linked to nuclear transport [36].  Redundant, functional 
roles among Scyl family members are unclear, but it should be noted that Scyl1 knockdown 
shares a similar Golgi fragmentation phenotype as PACE1 knockdown [16]. 
The connection, if any, between PACE1’s role in regulating Golgi membrane tubulation 
and its association with ezrin is unknown.  Interestingly, the screen also identified LIMK2 as a 
potential regulator of BFA-induced Golgi membrane tubulation.  It was previously reported that 
LIMK1, along with cofilin, positively regulates membrane tubules from the TGN in a 
filamentous actin-dependent manner [37].  It is tempting to speculate that LIMK2 may have 
effects on BFA-induced membrane tubulation, while LIMK1 was not identified in the screen as 
it primarily tubulates the TGN, which exhibits phenotypes different from those of the Golgi 
cisternae stack upon BFA treatment [38].  As PACE1 was originally discovered to interact with 
ezrin, which is involved in linking signal transduction between transmembrane receptors to the 
actin cytoskeleton, it will be interesting to determine whether the actin cytoskeleton may play 
important roles in generating membrane tubules [14].  Previous reports support this possibility by 
showing that membrane tubules can form in an actin-dependent fashion, without requiring 
microtubules [39-40]. 
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Although this study narrowly focused on a single hit gleaned from the siRNA screen, 
many other intriguing hits may provide roles in Golgi membrane tubulation and/or Golgi 
membrane dynamics, including lipid-modifying kinases.  Among these are diacylglycerol 
kinases (DAGKs).  Previous reports already suggest that they may be required for the early 
formation of membrane tubules [41].  However, it remains difficult to definitely conclude how 
DAGKs may directly participate in forming membrane tubules.  DAGKs modulate levels of both 
diacylglycerol (DAG) and phosphatidic acid (PA), resulting in downstream signal transduction 
pathways that encompass a diverse expanse of physiological functions [42].  Likewise, the 
DAGK-related ceramide kinase (CERK) was also identified as a potential regulator of Golgi 
membrane tubulation and has been observed to localize to the Golgi, and ceramide itself is 
thought to play important roles in deforming the membrane [43-44].  Other intriguing hits 
include the family of A-kinase anchoring proteins (AKAPs), which potentially serve to spatially 
and temporally compartmentalize signal transduction among subcellular domains [45].  Many 
AKAP proteins remain unstudied but interestingly, one such protein, BFA-inhibited GEF 2 
(BIG2), possesses AKAP domains and partially localizes to the Golgi in a way where it may link 
the cyclic AMP and ARF pathways [46].  
This study focused primarily on a single protein, PACE1, whose knockdown inhibited 
BFA-induced Golgi tubulation.  However, the screen also identified proteins whose knockdown 
enhanced BFA-induced Golgi dispersal (thus, would be negative regulators of Golgi function).  
A majority of the activating hits correspond to proteins involved in cell cycle regulation or have 
unknown functions.  Hits associated with cell cycle regulation may have unintended side-effects, 
but this group of putative negative regulators of Golgi function provide many opportunities for 
further study. 
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The siRNA screen described here has been very fruitful but several shortcomings should 
be noted.  First, some targets may not have been effectively knocked down by the library 
siRNAs.  Second, many targets  of the siRNA library may be specific to certain cell lineages and 
not be expressed in HeLa cells.  Third, our screen examined only BFA-induced membrane 
tubules of Golgi origin.  Other organelles such as endosomes and the ERGIC have been observed 
to possess dynamic membrane tubules, which were not assayed here [1].   
In conclusion, our results yielded both positive and negative regulators of BFA-induced 
Golgi membrane tubulation.  Further studies into these hits may provide additional clues in 
unraveling the complex regulatory mechanisms behind Golgi membrane tubulation within 
membrane trafficking. 
 
2.5. Materials and Methods 
Reagents and plasmids.  BFA and cycloheximide were purchased from Enzo Life Sciences, Inc.  
Both were dissolved in DMSO.  BFA was used at 5 μg/ml for the siRNA screen and at 1 μg/ml 
for all other experiments.  Mammalian expression plasmids for pcDNA3-PACE1-myc were 
obtained from Dr. A Bretscher (Cornell University).  p-ssHRP-FLAG was a gift from Dr. V. 
Malhotra (Centre for Genomic Regulation, Barcelona, Spain).  pIRES-ERGIC-53-GFP was a gift 
from Dr. R. Scheckman.  pEGFP-N1/VSVG-ts045-YFP was a gift from Dr. B. Storrie 
(University of Arkansas). 
Cell culture, transfection, and RNAi.  Media and culture reagents were purchased from 
Invitrogen (Carlsbad, CA).  Plastic culture vessels were purchased from Corning (Corning, NY).  
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Human epithelial (HeLa) cells were grown in modified Eagle’s minimal essential medium 
(MEM) with 10% fetal bovine serum (Life Technologies, CA) at 37ºC, 95% humidity, and 5% 
CO2.  For incubations at 19.5ºC or 37ºC at atmospheric CO2, MEM containing 1/10th normal 
sodium bicarbonate levels was used to maintain pH levels.  siRNA kinase library (Silencer® 
Human Kinase siRNA Library V2, AM80010V2, Ambion, Life Technologies, NY).  Double-
stranded RNA targeting human PACE1 were purchased from GenePharma Co., Ltd. (Shanghai, 
China) using sequences 5’ – GGUUAAUAAAGCUGCCAAGuu – 3’ (sense) and 3' - 
uuCCAAUUAUUUCGACGGUUC - 5' (anti-sense) for PACE1.  Library or individual RNA 
were transfected with Lipofectamine RNAiMax or Lipofectamine2000 in Opti-MEM 
(Invitrogen, CA), respectively, at a final RNA concentration of 30 nM.  Experiments were 
conducted at least 18 h after the initial RNA transfection.  RNAi-resistant constructs of the above 
were generated using QuickChange II (Agilent Technologies) using two silent mutations within 
the target siRNA sequence (above). 
High throughput siRNA screen.  HeLa cells stably expressing GalT-GFP were plated in black 
96-well plates with optical-grade clear bottoms (Molecular Devices, CA) at a density of 3,500 
cells/well.  24 h later, the cells were transfected with RNA from the Silencer® siRNA kinase 
library using Lipofectamine RNAiMAX (Invitrogen, CA) in Opti-MEM (Invitrogen, CA).  After 
5 h of incubation with RNA, media over wells were replaced with MEM with 10% FBS.  18 h 
later, cells were treated with 5 μg/ml of BFA in serum-free MEM for 10 min at 37ºC, followed 
by fixation in 3.7% formaldehyde for 10 min at room temperature.  After 3 washes with PBS, 
0.1% Hoechst stain in PBS was added for 15 min at room temperature to stain for nuclei.  After a 
final PBS wash, plates were sealed with parafilm and stored in PBS at 4ºC until further imaging 
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on an ImageXpress® Micro XL Widefield HCS System (Molecular Devices, CA) using a 20X 
air objective with the accompanying MetaXpress imaging software (Molecular Devices, CA).   
High throughput imaging and quantitative analysis.  MetaXpress software (Molecular 
Devices, CA) quantitated and imaged >300 cells per well.  Granular intensity, defined as average 
GalT-GFP fluorescence intensity per unit of area, was quantitated per cell.  Thresholds were set 
for minimum granular intensity to measure only intact, compact GalT-GFP structures while 
excluding dispersed, reticular GalT-GFP structures.  The siRNA library was screened three 
separate times in addition to control (no RNA).  Inhibitory hits were determined as possessing 
>20% average granular intensity when compared to control values while activating hits 
possessed <-15% average granular intensity when compared to control values.  Hits were 
determined from both combined siRNAs and individual siRNA results. 
 
Fluorescence microscopy and live-cell imaging.  Cells were prepared as described previously 
(Bechler et al., 2010).  Either GFP-tagged proteins or secondary antibodies conjugated to 
fluorescein isothiocyanate (FTIC), tetramethylrhodamine isothiocyanate (TRITC) were used at a 
dilution of 1:100.  Coverslips were mounted over Vectashield (Vector Laboratories, CA) 
mounting media, sealed with clear nail polish, and stored at -20ºC until further imaging at room 
temperature.  Wide-field epifluorescence was conducted on an Axioscope II (Carl Zeiss, Inc.) 
with Plan-Apo 40x/NA1.4 air objective mounted to a Orca II camera (Hamamatsu Photonics), 
utilizing Openlab software (PerkinElmer).  Spinning disk confocal images were taken on an 
Eclipse TE2000-U (Nikon) with Plan-Apo 60x/NA1.4 oil objective with an Ultraview LCI 
(PerkinElmer), a 1394 ORCA-ER camera (Hamamatsu Photonics) and Ultraview imaging 
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software (PerkinElmer).  Image analysis and Z-projections were conducted with ImageJ version 
1.45s software.  For live cell imaging, imaging was done at 37ºC using 35 mm tissue culture 
dishes with cover glass bottoms (World Precision Instruments, Inc., FL) over the Eclipse 
TE2000-U fitted with a custom-made housing and heater/blower equipped with a thermal 
regulator set to 37ºC. 
HRP secretion assay.  In ssHRP secretion experiments, 6 cm dishes of cells were first 
transfected with p-ssHRP-FLAG for 18 h.  Then the dishes were washed and incubated with 2.5 
ml MEM containing 10% FBS, where 50 μl media samples were collected every hour.  ssHRP-
FLAG levels in the media and lysates were assayed using 10 λ of media samples with 50 λ of the 
substrate, 3, 3’, 5, 5’-tetramethylbenzidine (Sigma-Alrich).  The reaction was stopped after 10’ 
using 50 λ of 1 M HCl and the plates were quantitated using a SpectraMax Plus384 
spectrophotometer (Molecular Devices, CA) with the absorption wavelength of 450nm.  Data 
points were normalized to total HRP expression, as described previously [6]. 
Golgi phenotype assays.  HeLa/GalT-GFP cells were categorized as fragmented as determined 
by possessing > 4 Golgi fragments.  Cells were categorized as tubulated by possessing >3 Golgi 
membrane tubules.  Cell were categorized as intact if the Golgi is neither fragmented, tubulated, 
or dispersed.  Minimum of 100 cells per condition were counted; n = 3. 
Cell lysates, antibodies, and immunoblotting.  Whole cell lysates were prepared through 
scraping cells in the presence of RIPA buffer with complete protease inhibitor cocktail (Roche 
Applied Science, Germany), and then analyzed by SDS-PAGE and Western via PVDF 
membranes.  Mouse anti-myc antibodies were diluted 1:1000 (Cell Signaling Technology, MA).  
Both rabbit and mouse HRP-conjugated secondary antibodies were diluted 1:20,000 (Jackson 
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ImmunoResearch, PA).  Mouse hybridoma media against an extracellular, ectopic epitope of 
VSVG-ts045-YFP was a gift from Dr. G. Whittaker (Cornell University) and used without 
dilution.  PACE1 antibody (SAB1407775, Sigma) was obtained from Sigma and used at 1:50 
dilution for immunofluorescence and 1:150 dilution for Western blot. Anti-α-tubulin antibody 
(Sigma) was diluted at 1:10,000 for Western and 1:1000 for immunofluorescence.  Anti-ManII 
and anti-M6PR were produced previously in-lab.  Anti-GPP130 (PRB-144C, Covance) was 
diluted 1:800 for immunofluorescence.  Alexafluor-conjugated Phalloidin was obtained as a gift 
from Dr. Anthon Bretscher (Cornell University).  Anti-myc antibody (9E10, Cell Signaling) was 
diluted 1:1000 for Western blot and 1:100 for immunofluorescence. 
VSVG-tsO45-YFP trafficking assay.  HeLa cells in dishes with glass coverslips (Mediatech) 
were transfected with VSVG-ts045-YFP for 5 h and then incubated at 40ºC for 18 h.  Media in 
dishes were then replaced with 20ºC 1/10th bicarb MEM with 10% FBS and cycloheximide (100 
μg/ml) and dishes were incubated over 20ºC water bath in a 4ºC room for 1.5 h.  Media in dishes 
were then replaced with 32ºC MEM with 10% FBS and dishes were incubated at 32ºC during 
collection of samples.  Following fixation, coverslips were washed and  then immunostained 
against an ectopically exposed epitope of VSVG without permeablizing cell membranes.  The 
ratio of ectopically trafficked VSVG was determined as ectopic, anti-VSVG fluorescence 
divided by VSVG-YFP fluorescence using ImageJ version 1.45s software. 
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Table 2.1.  Annotated list of hits that inhibited BFA-induced Golgi dispersal.  HeLa cells 
stably expressing GalT-GFP were treated with BFA (1 μg/ml) for 10’ and then fixed and stained 
against nuclei with Hoechst.  Cells were then quantitated for intact Golgi structures and either 
individual siRNA oligos or averaged results of all 3 oligos against a single target with averaged 
values of >20% more intact Golgi structures when compared to no-siRNA control cells were 
considered hits. 
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Green highlighted genes denote that a single siRNA promoted BFA-induced Golgi tubulation by an average greather than 
15% (n=3). All non-green genes show average values of all 3 siRNA oligos. 
  Gray highlighted genes denote that the average inhibition falls below 15% when subtracting the SEM. 
Gene Avg SEM Gene description 
AKAP8 -40.1 10.6 A kinase (PRKA) anchor protein 8 
RPS6KL1 -34.2 10.9 ribosomal protein S6 kinase-like 1 
MAP3K1 -30.1 3.1 mitogen-activated protein kinase kinase kinase 1 
CaMKIINalpha -29.0 16.0 calcium/calmodulin-dependent protein kinase II inhibitor 1 
PRKCG -26.8 5.3 protein kinase C, gamma 
ADRBK1 -26.6 7.3 adrenergic, beta, receptor kinase 1 
CALM2 -26.3 13.1 calmodulin 2 (phosphorylase kinase, delta) 
CNKSR1 -25.5 6.5 connector enhancer of kinase suppressor of Ras 1 
ATR -25.2 8.2 ataxia telangiectasia and Rad3 related 
SNARK -22.4 2.8 NUAK family, SNF1-like kinase, 2 
MAP3K6 -21.7 6.7 mitogen-activated protein kinase kinase kinase 6 
MAP4K4 -21.7 1.9 mitogen-activated protein kinase kinase kinase kinase 4 
NEK11 -21.4 2.1 NIMA (never in mitosis gene a)- related kinase 11 
VRK1 -20.7 2.6 vaccinia related kinase 1 
PTK9 -20.2 5.0 PTK9 protein tyrosine kinase 9 
KIAA1446 -19.8 4.5 KIAA1446 
TYK2 -19.0 2.6 tyrosine kinase 2 
CSNK1D -18.7 2.9 casein kinase 1, delta 
CaMKIINalpha -18.5 7.9 calcium/calmodulin-dependent protein kinase II inhibitor 1 
MYO3B -18.4 2.6 myosin IIIB 
BTK -18.4 4.3 Bruton agammaglobulinemia tyrosine kinase 
CIB2 -18.2 3.7 calcium and integrin binding family member 2 
LY6G5B -17.8 1.7 lymphocyte antigen 6 complex, locus G5B 
PIK3C2G -17.0 3.9 phosphoinositide-3-kinase, class 2, gamma polypeptide 
CHKB -16.9 6.3 choline kinase beta 
DLG3 -15.8 13.5 discs, large homolog 3 (neuroendocrine-dlg, Drosophila) 
PTK9 -15.7 5.2 PTK9 protein tyrosine kinase 9 
KIAA1765 -14.1 2.8 doublecortin and CaM kinase-like 3 
LOC283846 -14.0 9.1 LOC283846 
PIK3C2G -14.0 6.7 phosphoinositide-3-kinase, class 2, gamma polypeptide 
AKAP9 -13.3 12.0 A kinase (PRKA) anchor protein (yotiao) 9 
MAP3K7 -12.4 4.8 mitogen-activated protein kinase kinase kinase 7 
ROCK2 -12.1 4.2 Rho-associated, coiled-coil containing protein kinase 2 
KIS -11.9 3.6 U2AF homology motif (UHM) kinase 1 
AKAP7 -11.5 8.4 A kinase (PRKA) anchor protein 7 
DGKH -11.0 3.7 diacylglycerol kinase, eta 
STK24 -10.5 4.8 serine/threonine kinase 24 (STE20 homolog, yeast) 
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Table 2.2.  Annotated list of hits that enhanced BFA-induced Golgi dispersal.  HeLa cells 
stably expressing GalT-GFP were treated with BFA (1 μg/ml) for 10’ and then fixed and stained 
against nuclei with Hoechst.  Cells were then quantitated for intact Golgi structures and either 
individual siRNA oligos or averaged results of all 3 oligos against a single target with averaged 
values of >15% less intact Golgi structures when compared to no-siRNA control cells were 
considered hits. 
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Green highlighted genes denote that a single siRNA promoted BFA-induced Golgi tubulation by an average greather than 
15% (n=3). All non-green genes show average values of all 3 siRNA oligos. 
  Gray highlighted genes denote that the average inhibition falls below 15% when subtracting the SEM. 
Gene Avg SEM Gene description 
AKAP8 -40.1 10.6 A kinase (PRKA) anchor protein 8 
RPS6KL1 -34.2 10.9 ribosomal protein S6 kinase-like 1 
MAP3K1 -30.1 3.1 mitogen-activated protein kinase kinase kinase 1 
CaMKIINalpha -29.0 16.0 calcium/calmodulin-dependent protein kinase II inhibitor 1 
PRKCG -26.8 5.3 protein kinase C, gamma 
ADRBK1 -26.6 7.3 adrenergic, beta, receptor kinase 1 
CALM2 -26.3 13.1 calmodulin 2 (phosphorylase kinase, delta) 
CNKSR1 -25.5 6.5 connector enhancer of kinase suppressor of Ras 1 
ATR -25.2 8.2 ataxia telangiectasia and Rad3 related 
SNARK -22.4 2.8 NUAK family, SNF1-like kinase, 2 
MAP3K6 -21.7 6.7 mitogen-activated protein kinase kinase kinase 6 
MAP4K4 -21.7 1.9 mitogen-activated protein kinase kinase kinase kinase 4 
NEK11 -21.4 2.1 NIMA (never in mitosis gene a)- related kinase 11 
VRK1 -20.7 2.6 vaccinia related kinase 1 
PTK9 -20.2 5.0 PTK9 protein tyrosine kinase 9 
KIAA1446 -19.8 4.5 KIAA1446 
TYK2 -19.0 2.6 tyrosine kinase 2 
CSNK1D -18.7 2.9 casein kinase 1, delta 
CaMKIINalpha -18.5 7.9 calcium/calmodulin-dependent protein kinase II inhibitor 1 
MYO3B -18.4 2.6 myosin IIIB 
BTK -18.4 4.3 Bruton agammaglobulinemia tyrosine kinase 
CIB2 -18.2 3.7 calcium and integrin binding family member 2 
LY6G5B -17.8 1.7 lymphocyte antigen 6 complex, locus G5B 
PIK3C2G -17.0 3.9 phosphoinositide-3-kinase, class 2, gamma polypeptide 
CHKB -16.9 6.3 choline kinase beta 
DLG3 -15.8 13.5 discs, large homolog 3 (neuroendocrine-dlg, Drosophila) 
PTK9 -15.7 5.2 PTK9 protein tyrosine kinase 9 
KIAA1765 -14.1 2.8 doublecortin and CaM kinase-like 3 
LOC283846 -14.0 9.1 LOC283846 
PIK3C2G -14.0 6.7 phosphoinositide-3-kinase, class 2, gamma polypeptide 
AKAP9 -13.3 12.0 A kinase (PRKA) anchor protein (yotiao) 9 
MAP3K7 -12.4 4.8 mitogen-activated protein kinase kinase kinase 7 
ROCK2 -12.1 4.2 Rho-associated, coiled-coil containing protein kinase 2 
KIS -11.9 3.6 U2AF homology motif (UHM) kinase 1 
AKAP7 -11.5 8.4 A kinase (PRKA) anchor protein 7 
DGKH -11.0 3.7 diacylglycerol kinase, eta 
STK24 -10.5 4.8 serine/threonine kinase 24 (STE20 homolog, yeast) 
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CHAPTER 3 
 
DAG Kinase (DGK)-γ Regulates Golgi Membrane Tubulation 
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3.1. Abstract 
 
 Membrane trafficking is a vital process in sorting and transporting protein and membrane 
cargo towards numerous membranous compartments within eukaryotic cells.  This highly 
complicated process relies on many different proteins and lipid species in order to maintain 
constant intracellular traffic.  Defects in this process yield numerous disease states, such as 
neurodegeneration.  The most commonly observed trafficking vessels include coated vesicles 
and membrane tubules.  In contrast to coated vesicles, membrane tubules remain relatively 
understudied but are prominent features of the mammalian Golgi complex.  Although previous 
studies have established critical roles for membrane tubules in trafficking routes, the regulatory 
mechanism behind membrane tubulation is largely unknown.  In this study, we analyzed the 
involvement of diacylglycerol kinases (DGKs) in membrane tubulation and found that they may 
participate in Golgi membrane tubule biogenesis.  Furthermore, we observed that one specific 
isoform, DGK-γ, is important for membrane tubulation and its subsequent loss via siRNA 
knockdown leads to Golgi fragmentation, inhibition of anterograde trafficking of both soluble 
and transmembrane proteins, and disruption of Golgi ribbon formation.  Further studies on 
DGKs may help shed light on their possible roles as novel regulators of both membrane 
tubulation and trafficking. 
 
3.2. Introduction 
 
Diacylglycerol (DAG) is phosphorylated by diacylglycerol kinases (DGKs) to yield 
phosphatidic acid (PA) (Figure 1.7).  Both DAG and PA serve as active lipid second messengers 
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to influence a diverse array of functions in eukaryotic cells [1-2].  DAG is an uncharged lipid 
that partakes in numerous membrane trafficking roles through recruiting or activating proteins, 
with examples that include protein kinase C (PKC) at the Golgi complex [3], Munc13-1 at pre-
synaptic vesicles [4], ARF GTPase activating protein (ARF GAP) at the Golgi [5], and protein 
kinase D (PKD) at the trans-Golgi network (TGN) [6].  On the other hand, PA has been reported 
to provide vital roles in membrane fusion during both vesicular secretion [7] and mitochondrion 
fusion [8], which is possibly attributed to its conically-shaped structure favoring negative 
membrane curvature [9].  While there has been significant progress in establishing roles for 
DAG and DGK in membrane trafficking, little is known about their roles in membrane 
tubulation.   
The nine known isoforms of human DGKs are separated into five classes, depending on 
the shared protein domains (Table 3.1).  Although most have unknown or uncharacterized 
functions, some isoforms have been partially characterized.  For example, DGK-α translocates 
from a diffuse localization to membranous structures upon treatment with the DGK inhibitor 
R59022 [10] or to the nuclear matrix in rat thymocytes in a phosphorylation-free manner upon 
treatment with the mitogen concanavalin A [11].   
Little information is available about the biochemical regulation of DGKs.  For Type I 
DGKs, calcium is a known modulator.  Calcium could serve to activate Type I DGKs through 
binding to the EF-hand motif, where the EF-hand motifs could be auto-inhibiting the DGKs  
[12].  Studies have shown certain lipid species, such as phosphatidylserine (PS) can activate 
Type I DGKs such as DGK-α, Type IV DGKs, and Type V DGK-θ [13] while inhibiting DGK-ε 
and Type II DGKs [14].  Other lipids such as sphingosine and phosphatidylinositol phosphates 
(PIPs) can also activate specific DGKs but not others [15].  The mechanisms by which these  
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  Type Localization Notable domains Functions 
DGK-α I 
TGN, endosomes, 
Golgi, PM, 
nucleus 
Recoverin homology 
like, EF-hands, C1 
Membrane ruffling, 
apoptosis, Src signal 
transduction, thymic 
regulation 
DGK-β I 
Membrane 
structures 
Unknown 
DGK-γ I Nucleus, PM Highly expressed in brains 
DGK-δ II Nucleus 
PH, C1 
Supresses ER-to-Golgi traffic 
DGK-η II Unknown   
DGK-κ II PM EPAP repeat, PH, C1   
DGK-ε III Nucleus C1, 
Competitively inhibited by 
ceramide 
DGK-ζ IV 
Nucleus, 
cytoplasm C1, MARCKS, Ank 
repeat, PDZ-domain-
binding 
Rac regulator, inflammation, 
innate immunity, neurite 
formation, leptin signaling 
DGK-ι IV 
Nucleus, 
cytoplasm 
Unknown 
DGK-θ V   
Membranes, 
nucleus 
Proline rich, PH, Ras 
binding 
Unknown 
 
Table 3.1. Table of known diacylglycerol kinases, their localization, domains, and 
functions. 
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lipids regulate DGK activity remain unknown.  Phosphorylation can also play a role in regulating 
DGKs, as studies have shown that DGK-α, DGK-δ, and DGK-θ, can be phosphorylated by PKC 
[16] and Src [17].  Phosphorylation of DGKs can have diverse consequences, as PKC-induced 
phosphorylation of DGK-δ leads to its removal from the PM while phosphorylation of DGK-ζ 
leads to both its removal from the nucleus and reduced catalytic activity [18-19].   
In addition to regulation via phosphorylation and lipids, DGKs can possibly be regulated 
through protein-protein interactions.  All DGKs additionally have C1 domains that closely mirror 
those of PKC [20] and studies have shown that at least in DGK-θ, the C1 domains may also 
contribute to kinase activity [21].  Interestingly, C1 domains do not necessarily bestow DAG-
binding capabilities among the DGK isoforms, with studies showing that only DGK-β and DGK-
γ could bind to DAG analogues such as phorbol esters via their C1 domains [22], while other 
isoforms utilize them to bind to other proteins [23].  Protein interactions with C1 domains may 
be more ubiquitous than previously thought, as seven DGK isoforms are capable of binding to β-
arrestin [24], most likely through their C1 domains, as it is the only shared domain across all 
DGK members [25]. 
Within the scope of membrane trafficking, reports have shown that both DAG and PA 
may regulate this process, where PA is required for COPI vesicle fission [26] and DAG is 
required to recruit PKD to the TGN for membrane tubulation and subsequent trafficking to the 
PM [6, 27].  DAG has also been reported to be required for Golgi membrane tubule formation 
[28].  Evidence supporting that DGKs are involved in membrane trafficking was provided by 
previous observations that one particular DGK, DGK-ζ, interacts with sorting nexin 27 (SNX27) 
to help mediate endosomal recycling [29].  This is quite relevant to membrane tubulation as 
many sorting nexins are implicated in membrane tubules that are both clathrin-dependent and  
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independent within the PM and endosomes [30-33], albeit by bin-amphiphysin-rvs (BARs)-
dependent mechanisms that involves protein oligomerization. 
In a previous high throughput siRNA screen of the human kinome to identify novel 
regulators of Golgi membrane tubulation and function, we identified several members of the 
DGK family as strong hits (Chapter 2).  We reasoned that DGKs could potentially play roles in 
membrane tubulation by virtue of their activity in generating PA from DAG, where PLAs, such 
as iPLA1γ, can then cleave cylindrically-shaped PA into conically-shaped lysophosphatidic acid 
(LPA) to yield membrane tubules [34].  It is additionally possible that the local changes in 
DAG/PA levels induced by DGKs can facilitate membrane trafficking events. 
 
3.3. Results 
 
3.3.1. DGK-γ Knockdown Inhibits BFA-Induced Golgi Tubulation 
To determine whether DGKs may play roles in Golgi membrane tubulation, siRNAs 
against eight isoforms of DGK (-α, -β, -γ, -δ, -ε, -ι, -θ, and -ζ) were transfected into HeLa cells 
stably expressing a GFP-fused trans-Golgi resident protein, galactosyltransferase (HeLa/GalT-
GFP) and subsequently assayed for their effects on inhibiting BFA-induced Golgi dispersal.  
BFA serves as an excellent model for studying Golgi membrane tubules, as membrane tubules 
are both highly dynamic and elusive at steady-state levels.  Additionally, BFA induces complete 
loss of intact, juxtanuclear Golgi structures as the result of its hyper-activation of membrane 
tubules, which subsequently traffic in a retrograde fashion to fuse with ER membranes [35].  As 
GalT-GFP trafficks from the Golgi complex to the ER, its average fluorescent intensity per area 
decreases because the mammalian ER possesses five-fold greater membrane surface area than 
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the Golgi complex [36-37].  We utilized three distinct siRNA oligos against each DGK gene in 
assessing their ability to affect BFA-induced Golgi loss.  Interestingly, knockdown of all eight 
isoforms appears to hinder BFA-induced Golgi loss with a minimum of 20% inhibition when 
compared to untransfected control cells (Figure 3.1A).  Among the eight isoforms, DGK-γ 
showed the strongest phenotype with three siRNAs averaging 46% ± 7.9% (standard error of 
mean, SEM) inhibition of BFA-induced Golgi loss.  More specifically, one siRNA exhibited the 
greatest efficacy with 53.6% ± 14.5% (SEM) inhibition when compared to control cells (Figure 
3.1B).  Western blot analysis on whole-cell HeLa lysates confirmed that this siRNA reduced 
levels of transiently expressed GFP-DGK-γ in HeLa cells.  Furthermore, transfection with an 
RNAi-resistant construct (GFP-DGK-γR) completely restored GFP-DGK-γ protein levels (Figure 
3.2A).  DGK-γ knockdown cells displayed ~90% reduced protein levels when compared to 
control, while overexpression of GFP- DGK-γR) yielded similar protein levels as control cells 
overexpressing GFP-DGK-γ without siRNA transfection (Figure 3.2B). 
After observing that DGK-γ knockdown interferes with BFA-induced Golgi loss, we 
inferred that DGK-γ might be disrupting Golgi membrane tubulation, which BFA robustly 
promotes.  To assess whether DGK-γ may be involved in this process, HeLa/GalT-GFP cells 
were transfected with siRNA against control (scrambled siRNA) or DGK-γ and then treated with 
BFA (1 μg/ml), followed by fixation after various time intervals.  Within 6 minutes of BFA  
treatment, almost no control cells harbored intact non-tubulated Golgi structures (Figure 3.3A) 
but roughly 65% of cells harbored tubulated Golgi membranes (Figure 3.3B) with the remaining 
35% cells displaying dispersed Golgi structures (data not shown).  In contrast to control cells, 
DGK-γ knockdown cells displayed significantly more intact non-tubulated Golgi structures at 6  
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Figure 3.1.  Diacylglycerol kinases inhibit BFA-induced Golgi dispersal.  (A) HeLa cells 
stably expressing galactosyltransferase-GFP (GalT-GFP) were transfected with 3 separate and 
unique siRNAs against 8 different isoforms of DGKs and then treated with BFA (1 μg/ml) for 
10’ and then fixed.  Cells with intact Golgi structures, determined by GalT-GFP fluorescence, 
were quantitated and averaged after pooling siRNA data against respective DGK isoforms.  (B)  
Average inhibition of BFA-induced Golgi dispersal for individual siRNAs against DGK-γ are 
shown, extracted from same experiments in (A).  Error bars represent SEM for n=3.  Bar graphs 
represent mean values. 
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Figure 3.2.  DGK-γ siRNA reduces overexpressed GFP-tagged DGK-γ.  (A) Western blot 
analysis of whole cell HeLa lysates transfected with combinations of pEGFP-C3/DGK-γ (GFP-
DGK-γ), RNAi-resistant construct (GFP-DGK-γR), control siRNA, and DGK-γ-siRNA.  (B) 
Densitometry analysis of (A).  Error bars indicate SEM for n = 3.  Bar graphs represent mean 
values. 
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minutes, which was attributed to ~30% of the cells (Figure 3.3A).  Similarly, DGK-γ knockdown 
decreased the number of cells containing tubulated Golgi structures at 6 minutes from 65% as 
seen in control cells down to ~35% (Figure 3.3B).  DGK-γ knockdown clearly slowed down the 
effects of BFA-induced Golgi tubulation, and these defective phenotypes were significantly 
reversed upon overexpression of an RNAi-resistant construct that bears silent mutations within 
the siRNA target site, GFP-fused DGK-γ (GFP-DGK-γR) (Figures 3.4A, 3.4B). 
 
3.3.2. DGK-γ Knockdown Disrupts Golgi Structure Homeostasis 
After establishing potential roles for DGK-γ in Golgi membrane tubulation, we next 
sought to determine whether DGK-γ knockdown of Golgi membrane tubulation could affect the 
structural homeostasis of the Golgi complex.  Previous reports have shown that Golgi membrane 
tubules are required for intra-cisternal continuities within the Golgi [38-39] and for the assembly 
of an intact Golgi cisternal ribbon from fragmented Golgi mini-stacks [40-41].  In the latter 
circumstance, BFA has proven to be a useful model system because it can be washed out from 
cells to readily induce the formation of Golgi mini-stacks from the ER [42], which subsequently 
form an intact Golgi ribbon in a PLA2- and membrane tubule-dependent manner [39].   
We therefore investigated whether DGK-γ knockdown could disrupt the reformation of 
an intact Golgi ribbon following BFA washout from cells.  HeLa/GalT-GFP cells were 
transfected with siRNA against either control or DGK-γ and then treated with BFA (1 μg/ml) for 
20 minutes.  After washing the drug from the culture vessels, the cells underwent recovery and 
Golgi reformation over 90 minutes.  Control cells were able to completely reform intact, 
juxtanuclear Golgi ribbon structures, but DGK-γ knockdown cells exhibited significant defects in 
Golgi ribbon reformation, showing fragmented Golgi mini-stacks in the form of scattered puncta 
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throughout the cell (Figure 3.5A).  Knocking down DGK-γ significantly increased fragmented 
Golgi structures after BFA washout relative to control cells (Figure 3.5B).  Time-lapse imaging 
clearly showed that Golgi mini-stacks were able to form for both control and DGK-γ knockdown 
cells but in DGK-γ cells, Golgi mini-stacks failed to coalesce into an intact Golgi ribbon 
structure (Figure 3.5D).  Furthermore, DGK-γ knockdown interfered with Golgi structural 
homeostasis, as HeLa/GalT-GFP cells transfected with DGK-γ siRNA also exhibited a similar 
increase in Golgi fragmentation relative to control cells even without the use of BFA (Figure 
3.5C).   
The Golgi fragments induced by DGK-γ knockdown were confirmed to be mini-stacks, 
as the trans-Golgi marker, GalT-GFP, co-localized with both cis-Golgi marker GPP130 and 
medial-Golgi marker, ManII (Figure 3.6).  Previous studies have shown that disruptions in 
cytoskeletal processes can lead to Golgi fragmentation, including microtubule depolymerization 
[43], filamentous actin (F-actin) polymerization [44], microtubule motor complexes [45], and 
myosin motors [46].  However, cytoskeletal defects in DGK-γ knockdown cells were excluded, 
as both microtubule- and actin-filaments appear normal when compared to control cells (Figure 
3.6).  Similarly, coat proteins such as β-COP and AP1 remain primarily co-localized within 
GalT-GFP labeled Golgi membranes regardless of DGK-γ knockdown (Figure 3.6). 
 
3.3.3. DGK-γ Knockdown Disrupts Membrane Trafficking 
Numerous studies have established a requirement for Golgi membrane tubules within the 
context of membrane trafficking, particularly the secretion of protein and membrane cargo 
passing through the Golgi cisternae stacks [47-48].  As our results implicated DGK-γ in Golgi 
membrane tubulation, we next explored whether DGK-γ knockdown leads to significant defects  
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Figure 3.3.  DGK-γ knockdown inhibits BFA-induced Golgi membrane tubulation.  (A) 
HeLa cells were transfected with siRNA against control or DGK-γ for 18 h and then treated with 
BFA for varying intervals.  Cells were categorized under Golgi phenotypes corresponding to 
intact non-tubulated Golgi or (B) tubulated Golgi (as possessing >3 Golgi membrane tubules).  
Error bars indicate SEM of n=3.  Two-tailed P-values of <0.01 are denoted by **.  
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Figure 3.4.  DGK-γ rescue restores BFA-induced Golgi membrane tubulation in DGK-γ 
knockdown cells.  A) HeLa cells were transfected with siRNA against control or DGK-γ and 
empty pEGFP vector or RNAi-resistant GFP-DGK-γ for 18 h.  Cells were then treated with BFA 
for varying intervals.  Cells were categorized under Golgi phenotypes corresponding to intact 
non-tubulated Golgi or (B) tubulated Golgi (as possessing >3 Golgi membrane tubules).  Error 
bars indicate SEM of n=3.  Two-tailed P-values of <0.01 are denoted by **. 
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in membrane trafficking from the Golgi.  We therefore utilized an expression construct of 
secretory horseradish peroxidase (ssHRP), which is secreted from the cell while maintaining its 
catalytic activity to permit quantification of the protein within the media [49].  HeLa cells were 
transfected with ssHRP along with siRNA control or DGK-γ and were permitted to secrete 
ssHRP into fresh media.  HeLa cells with DGK-γ knocked down exhibited significant decreases 
of ssHRP within the media over time, with secretion rates roughly 30% slower than control cells 
(Figure 3.7A).  This defect in secretion was effectively restored through rescue with an 
overexpression construct of RNAi-resistant GFP-DGK-γ (Figure 3.7B). 
Studies have additionally shown that Golgi membrane tubules serve prominent roles in 
membrane trafficking from the TGN, particularly cargo exit from the TGN destined for the 
plasma membrane and endosomes [50-51].  We next explored whether DGK-γ knockdown could 
impact membrane traffic exiting the TGN through the use of a temperature-sensitive mutant 
version of tsO45-VSVG-YFP (VSVG-YFP).  HeLa cells were transfected with the construct for 
this protein along with siRNA against control or DGK-γ and then subjected to a series of 
aforementioned temperature blocks in order to gauge TGN-to-plasma membrane trafficking.  
Surface expressed VSVG levels were quantitated with the use of anti-VSVG antibodies on non-
permeablized cells.  After 45 minutes from the point of TGN release (shift from 20ºC to 32ºC), 
VSVG-YFP was present on the plasma membrane, as determined by labeling with anti-VSVG 
antibodies, for both control and DGK-γ knockdown cells (Figure 3.8).  However, DGK-γ 
knockdown cells experienced a significant delay in trafficking VSVG-YFP from the TGN, as 
relatively large amounts of the protein were still visible within the TGN (Figure 3.8).  VSVG- 
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Figure 3.5.  DGK-γ knockdown disrupts Golgi structure homeostasis.  (A) HeLa cells stably 
expressing GalT-GFP were transfected with siRNA against either control or DGK-γ and then 
treated with BFA (1 μg/ml) for 20 min, followed by drug washout and recovery in serum 
medium for 90 min at 37ºC.  Scale bar represents 10 μm.  (B) Cells from (A) were quantified as 
containing fragmented Golgi structures, as determined by possessing >4 Golgi fragments per cell 
and displayed as percentage of entire populations.  (C)  HeLa cells stably expressing GalT-GFP 
were transfected with siRNA against control or DGK-γ for 18 h and then assayed for fragmented 
Golgi structures as in (B) but without any BFA usage.  Error bars in (B) and (C) indicate SEM of 
n=3.  Two-tailed P-values of <0.01 are denoted by **.  (D)  Live-cell imaging of cells as in (A), 
using a Z-axis projections of slices throughout whole cells.  Scale bar represents 10 μm. 
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Figure 3.6.  DGK-γ knockdown-induced Golgi fragments co-localize with Golgi markers 
and coat proteins, while the cytoskeleton remains intact.  HeLa cells stably expressing the 
trans-Golgi marker, GalT-GFP, were transfected with siRNA against either control or DGK-γ for 
18 h and then labeled with immunofluorescence against Golgi markers such as cis-Golgi 
GPP130, medial-Golgi mannosidase-II (ManII), and trans-Golgi network (TGN) marker 
mannose6-phosphate receptor (M6PR).  Scale bar represents 10 μm. 
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Figure 3.7.  DGK-γ knockdown disrupts ssHRP anterograde trafficking.  (A) Simple linear 
regression curves fitted to measured protein levels of ssHRP secreted into the media by HeLa 
cells transfected with siRNA against control or DGK-γ.  Equations of regression curves are 
shown.  Two-tailed P-values of <0.05 are indicated by *.  (B) Same as in (A) but with rescue 
using empty pEGFP or RNAi-resistant GFP-DGK-γ for control and DGK-γ knockdown cells, 
respectively.  Error bars indicate SEM of n=3.  Data points represent mean values. 
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YFP secretion could be quantitated through the simple measurement of the ratio of fluorescence 
of ectopically labeled VSVG versus that of VSVG-YFP.  Using this method, DGK-γ knockdown 
cells showed a significant delay in VSVG-YFP secretion, when compared to control cells, by 45 
minutes after temperature release from the TGN (Figure 3.9). 
 
3.4. Discussion 
 
In this study, we demonstrated that siRNAs against multiple DGKs inhibited BFA-
induced Golgi dispersal.  We then focused on a single member of this family, DGK-γ, and 
showed that knocking down DGK-γ expression resulted in Golgi fragmentation, Golgi 
reformation defects, and decreases in anterograde secretion of both soluble and transmembrane 
protein cargo, all possibly the result of its involvement in membrane tubulation.  The results of 
the knockdown experiments are likely not due to unintended side effects as rescue via an RNAi-
resistant, GFP-tagged DGK-γ construct restored all of these phenotypes.   
Knockdown of DGK-γ did not yield complete inhibition of tubulation, which could be 
caused by or result from several factors.  First, although knockdown was extensive (~90%), the 
remaining DGK-γ could provide enough enzymatic activity to influence membrane tubule 
formation.  Second, other DGK isoforms may play redundant roles, which would be consistent 
with our siRNA screen results.  And, third, DGK-γ may not directly induce membrane tubulation 
but instead serve as a modulator. 
Interestingly, previous reports observed that DGK-γ was soluble but primarily associated 
with the cytoskeleton in Purkinje cells [52].  This conflicts with other reports proposing that the  
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Figure 3.8.  DGK-γ knockdown decreases VSVG-YFP TGN to PM trafficking.  HeLa cells 
were transfected with ts045-VSVG-YFP (VSVG-YFP) along with siRNA against either control 
or DGK-γ and then incubated at 40ºC to sequester VSVG-YFP within the ER.  A temperature 
shift to 20ºC for 3 h blocks VSVG-YFP within the trans-Golgi network (TGN) and a 
temperature shift to 32ºC then permits VSVG-YFP to traffick to the plasma membrane (PM).  
All images show cells at 0 or 45 min at 32ºC.  Scale bar represents 10 μm. 
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Figure 3.9.  DGK-γ knockdown decreases VSVG-YFP secretion kinetics.  HeLa cells were 
transfected with ts045-VSVG-YFP (VSVG-YFP) along with siRNA against control or DGK-γ 
and then incubated at 40ºC to sequester VSVG-YFP within the ER.  Cells were then shifted to 
20ºC for 3 h to accumulate VSVG-YFP into the trans-Golgi network (TGN), where a subsequent 
temperature shift to 32ºC allowed VSVG-YFP to traffick from the TGN to the plasma membrane 
(PM).  VSVG on the plasma membrane was then detected using an anti-VSVG antibody which 
recognizes an ectopic epitope, and antibody incubations were carried out in non-permeablized 
cells.  The mean ratio of anti-VSVG fluorescence over VSVG-YFP fluorescence were plotted 
alongside a simple linear regression curve fitted to the data.  Equations represent slopes of 
regression curves.  Error bars indicate SEM of n=3.  Two-tailed P-values of <0.001 are denoted 
by ***. 
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entire C1 domain of DGK-γ acts as a nuclear localization sequence (NLS) [53].  However, this 
can be reconciled through differences between cell types. 
Formulating a model for DGK-γ in membrane tubulation becomes quite complicated as 
both its lipid substrates and products may partake in membrane trafficking, and sometimes even 
in similar processes.  For example, DAG and PA have been shown to be essential for fission of  
membranes from the TGN [6] and COPI vesicles from cis-Golgi cisternae [26], respectively, and 
both can induce membrane fusion events [7, 54].  Their redundant roles in membrane fission and 
fusion have been suggested to be the result of their strongly conical shapes [55].  Loss of DGK-γ 
could possibly decrease PA levels and therefore lower membrane tubule abundance.  Numerous 
studies have focused on the roles of phospholipase D (PLD), which removes the choline head 
group from phosphatidylcholine (PC) to generate PA, and how the subsequent pool of PA is 
important for many membrane trafficking events [56].  Similarly, disruption of DGK-γ could 
conceivably yield similar phenotypes as PLD defects, as both would result in decreased PA 
levels.  However, substrate availability for both PLD and DGK may be important in deciphering 
whether PA origin is significant and if so, PLD may possibly generate more PA than DGK, as 
PC makes up half of all Golgi membranes while DAG levels are very small [57].  More studies 
are required on DGKs in order to establish a clearer role for them within the scope of membrane 
trafficking and tubulation. 
 
3.5. Materials and methods 
 
Materials.  BFA and cycloheximide were purchased from Enzo Life Sciences, Inc. Both were 
dissolved in DMSO. Mammalian expression plasmid for pEGFP-C3-GFP-DGKγ was obtained 
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from Harvard PlasmID. pSS-HRP-FLAG was a gift from Dr. V. Malhotra (Centre for Genomic 
Regulation, Barcelona, Spain). pIRES-ERGIC-53-GFP was a gift from Dr. R. Scheckman. 
 
Cell culture, transfection, and RNAi.  Media and culture reagents were purchased from 
Invitrogen (Carlsbad, CA). Plastic culture vessels were purchased from Corning (Corning, NY). 
Human epithelial (HeLa) cells were grown in modified Eagle’s minimal essential medium 
(MEM) with 10% fetal bovine serum (Life Technologies, CA) at 37ºC, 95% humidity, and 5% 
CO2. For incubations at 19.5ºC or 37ºC at atmospheric CO2, MEM containing 1/10th normal 
sodium bicarbonate levels was used to stabilize media pH levels. 
siRNAs against all DGK isoforms were obtained from an siRNA kinase library (Silencer® 
Human Kinase siRNA Library V2, AM80010V2, Ambion, Life Technologies, NY).  Additional 
double-stranded RNA targeting human DGKγ was purchased from GenePharma Co., Ltd. 
(Shanghai, China) using sequences 5’ – GGGUGGGAGCCUCAAACAAtt – 3’. RNA was 
transfected with Lipofectamine RNAiMax or Lipofectamine2000 in Opti-MEM (Invitrogen, 
CA), respectively, at a final RNA concentration of 30 nM. Experiments were conducted 24 h 
after the initial RNA transfection. RNAi-resistant constructs of the above were generated using 
QuickChange II (Agilent Technologies) using two silent mutations within the target siRNA 
sequence (above). 
 
Fluorescence microscopy and live-cell imaging.  Cells were prepared as described previously 
(Bechler et al., 2010). Either GFP-tagged proteins or secondary antibodies conjugated to 
fluorescein isothiocyanate (FTIC), tetramethylrhodamine isothiocyanate (TRITC) were used at a 
dilution of 1:100. Coverslips were mounted over Vectashield (Vector Laboratories, CA) 
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mounting media and stored at -20ºC until further imaging at room temperature. Wide-field 
epifluorescence was conducted on an Axioscope II (Carl Zeiss, Inc.) with Plan-Apo 40x/NA1.4 
air objective mounted to a Orca II camera (Hamamatsu Photonics), utilizing Openlab software 
(PerkinElmer). Spinning disk confocal images were taken on an Eclipse TE2000-U (Nikon) with 
Plan-Apo 60x/NA1.4 oil objective with an Ultraview LCI (PerkinElmer), a 1394 ORCA-ER 
camera (Hamamatsu Photonics) and Ultraview imaging software (PerkinElmer). For live cell 
imaging, imaging was done at 37ºC using 35 mm tissue culture dishes with cover glass bottoms 
(World Precision Instruments, Inc., FL) over the Eclipse TE2000-U fitted with a custom-made 
housing and heater/blower equipped with a thermal regulator set to 37ºC. 
 
HRP secretion assay.  In ssHRP secretion experiments, 6 cm dishes of cells were first 
transfected with p-ssHRP-FLAG for 24 h. Then the dishes were washed with and incubated with 
2.5 ml MEM containing 10% FBS, where 50 ul media samples were collected every hour. 
ssHRP-FLAG levels in the media and lysates were assayed via 3, 3’, 5, 5’-tetramethylbenzidine 
(Sigma-Alrich) and normalized to total HRP expression, as described previously [58]. 
 
Cell lysates, antibodies, and immunoblotting.  Cells were lysed by scraping dishes in the 
presence of RIPA buffer with complete protease inhibitor cocktail (Roche Applied Science, 
Germany). Lysates were analyzed by SDS-PAGE, transferred onto PVDF membranes (Whatman 
Inc., United Kingdom). Rabbit antibodies against GFP were diluted 1:1000 and were a gift from 
Dr. A. Bretscher (Cornell University). HRP-conjugated secondary antibodies against rabbit and 
mouse were diluted 1:20,000 (Jackson ImmunoResearch, PA).  
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APPENDIX 1 
 
Identifying regulatory mechanisms of PAFAH Ib 
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A1.1.  Introduction 
 
 Lipid remodeling enzymes such as phospholipases and lysophospholipid acyltransferases 
play important roles in generating membrane curvature to induce membrane tubulation at 
organelles such as the Golgi complex and endosomes.  Although recent studies have discovered 
numerous lipid remodeling enzymes to be involved in membrane tubulation, no direct proof is 
available on how lipid remodeling enzymes can induce membrane tubulation strictly alone 
through their catalytic activity.  One method in proving their involvement in membrane 
tubulation includes a reconstitution assay that utilizes purified proteins to establish the minimal 
machinery involved in membrane tubulation.  This study examines the regulatory mechanisms 
behind one particular phospholipase, called platelet activating factor acetylhydrolase (PAFAH) 
Ib, to establish the ideal requirements for an in vitro reconstitution assay. 
 
A1.2.  Results 
 
A1.2.1.  PAFAH Ib α1 binds to PI3P and PI4P monolayers 
 PAFAH Ib was previously identified as an important mediator in membrane tubulation 
and trafficking at the Golgi and endosomes [1-2].  The exact mechanism by which PAFAH Ib α 
subunits are targeted to the Golgi or endosomes is unclear, but apparently it does not require 
their catalytic activities [2].  Phosphoinositides are possible suspects as previous studies showed 
that they play important roles in serving as lipid signposts for the Golgi and endosomes to 
facilitate membrane trafficking events [3-5].  More specifically, phosphatidylinositol-4-
phosphate (PI4P) and phosphatidylinositol-3-phosphate (PI3P) are enriched within the Golgi 
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complex [6-7] and endosomes [4], respectively.  The trafficking roles of PIPs may be more 
promiscuous than currently believed, as recent studies have linked phosphoinositide-3-kinase 
(PI3K) to secretion from the TGN as well [8].  The roles of PIPs in membrane tubulation is 
unclear, but one study reported that a Golgi protein, GOLPH3, binds to PI4P at the TGN to link 
it to an unconventional myosin and filamentous actin to facilitate membrane tubule and vesicle 
formation [9]. 
 To investigate whether particular PIP species can recruit PAFAH Ib onto membranes, 
monolayers of PIPs were spotted onto nitrocellulose membranes, along with other lipids and 
cholesterol.  Subsequent incubation with purified PAFAH Ib α subunits, followed by standard 
Western immunoblotting protocol, revealed that PAFAH Ib α1 reproducibly binds to both PI3P 
and PI4P (Figure A1.1). 
 
A1.2.2. PAFAH Ib α1 binds to PI3P and PI4P liposomes 
 Although PAFAH Ib was capable of binding to PI3P and PI4P on nitrocellulose 
membranes (PIP strips), this did not reflect the physiological composition of either Golgi or 
endosomal membranes, both of which have large molar percentages of other lipids such as 
phosphatidylcholine (PC) [10].  To resolve this issue, unilamellar liposomes were formulated 
with PC:PS:PIP at a ratio of 80:20:0, 79:20:1, 75:20:5, and 70:20:10, where PIP species were 
increased at the expense of PC.  After addition of purified hemagglutinin (HA)-tagged PAFAH 
Ib α1 or α2, liposomes were spun down, separated from the supernatant, and then subjected to 
Western blotting.  Both α1-HA and α2-HA bound to PI3P and PI4P liposomes with an affinity 
that correlates with PIP molar percentage.  Likewise, both α1 and α2 presence within the 
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supernatant decreased as increasing amounts bound to liposomes (Figure A1.2).  This affinity is 
most likely specific, as both α1 and α2 failed to bind to liposomes containing PI(3,4)P2 (Figure 
A1.3). 
 
A1.2.3.  PAFAH Ib α1 binds to other proteins 
 Previous studies showed that bovine brain cytosol (BBC) possessed Golgi tubulation 
activity [11] and that further biochemical fractionation of BBC yielded a final gel filtration (GF) 
fraction that had >5,400 fold enrichment in tubulation activity.  Within this GF fraction, all three 
subunits of PAFAH Ib were detected via MALDI-TOF and Western blotting.  However, not all 
proteins were able to be identified, including proteins between 66 and 45 kDa.  Any combination 
of PAFAH Ib subunits is incapable of inducing Golgi membrane tubulation and requires a sub-
threshold amount of BBC.  This implied that PAFAH Ib α subunits required other proteins 
and/or cofactors present within the BBC.  To identify potential protein partners, HeLa cells were 
transfected with a α1-HA and α2-HA constructs.  After whole cell lysate preparation, the HA 
epitope was immunoprecipitated and then analyzed through SDS-PAGE and silver staining.  The 
silver stained gel showed copious amounts of α1-HA protein along with heavy and light chains 
of the anti-HA antibody (Figure A1.4).  Four specific bands were observed in the α1-HA lane, 
and two of these bands fall within the unidentified proteins range within the GF fraction.  Thus, 
it is likely that the tubulating activity of the GF fraction is due to a complex formed by PAFAH 
Ib α1/α2 along with their bound protein partners. 
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Figure A1.1.  PAFAH Ib α1 specifically binds to PI4P and PI3P.  500 pmol of lipids or 
cholesterol were spotted onto nitrocellulose membranes and permitted to dry.  The membrane 
was then incubated with purified PAFAH Ib α1 and processed using a standard Western blotting 
protocol.  PAFAH Ib α1 was then detected using anti-α1 antibody.  This figure was published by 
Bechler, M. E., Doody, A. M., Ha, K. D., Judson, B. L., Chen, I., Brown, W. J. “The 
phospholipase A enzyme complex PAFAH Ib mediates endosomal membrane tubule formation 
and trafficking,” Mol Cell Bio (2011) 22:2348-59. 
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Figure A1.2.  PAFAH Ib α1-HA and α2-HA specifically bind to PI3P- and PI4P-containing 
liposomes.  Purified PAFAH Ib α1-HA and α2-HA were added to liposome mixtures containing 
PC:PS:PI3P/PI4P at 80:20:0, 79:20:1, 75:20:5, and 70:20:10 molar ratios.  Liposomes were then 
pelleted, and both pellet and supernatant fractions were analyzed via SDS-PAGE/Western using 
anti-HA antibodies. 
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Figure A1.3.  PAFAH Ib α1-HA and α2-HA do not bind specifically to PI(3,4)P2.  Purified 
PAFAH Ib α1-HA and α2-HA were added to liposome mixtures containing PC:PS:PI(3,4)P2 at 
80:20:0, 79:20:1, 75:20:5, and 70:20:10 molar ratios.  Liposomes were then pelleted, and both 
pellet and supernatant fractions were analyzed via SDS-PAGE/Western using anti-HA 
antibodies. 
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Figure A1.4.  PAFAH Ib co-immunoprecipitates with additional proteins.  HeLa cells were 
transfected with α1-HA and then whole cell lysates were prepared using RIPA buffer.  Lysates 
were immunoprecipitated using anti-HA antibodies and then analyzed via SDS-PAGE and silver 
staining.  Specific bands immunoprecipitated with α1-HA are denoted by *.  Hyphens denote α1-
HA (30 kDa), heavy and light chains of anti-HA antibodies (50 kDa and 25 kDa, respectively). 
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A1.3. Discussion 
We showed that PAFAH Ib α1 bound strongly to PI3P and PI4P monolayers and that 
both α1 and α2 bound specifically to PI3P- and PI4P-containing liposomes.  PI3P and PI4P are 
present in endosomes and the TGN, respectively, and may serve as recruiting lipids for PAFAH 
Ib α subunits.  It remains unclear whether α1/α2 may be binding to these PIPs via their catalytic 
site or through some novel domain outside of the catalytic pocket.  Additionally, α1-HA was 
shown to co-immunoprecipitate with at least four specific proteins, with at least two proteins 
possibly found within the GF fraction as well.  Further studies are required in order to identify 
these proteins in order to decisively determine the minimal components required to establish an 
in vitro reconstitution assay for PAFAH Ib-based membrane tubulation. 
 
A1.4. Materials and methods 
 
Lipid-protein overlays (PIP strips/arrays).  Nitrocellulose membranes (Amersham Hybond-C 
Extra RPN203E) were cut into appropriate sizes and then spotted with lipids or PIP containing 
diC16 acyl chains.  Lipids were resuspended in chloroform and the resuspended into 1 mM stock 
solutions using spotting buffer, composed of chloroform:methanol (1:1) with 0.2% Ponceau S 
(Fluka 09276).  1 to 2 μl of diluted lipid was spotted onto the membrane.  After drying the 
membrane, protein was added to 5% non-fat dry milk in tris-buffered saline with Tween-20 
(TBS/T) o/n at 4ºC, followed by standard Western blotting protocols. 
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Liposome pulldown assay.  Liposomes were prepared using standard protocols, using pulldown 
buffer containing 0.1 M NaCl, 20 mM HEPES, 12.5 mM EGTA, and 0.1 μg/ml fatty-acid free 
BSA with a final pH of 7.2.  Liposomes were formulated with PC:PS:PIP at molar ratios from 
80:20:0 to 70:20:10, where PS levels were unchanged.  Liposomes were diluted to a final 
concentration of 1-2 mM and then 60 μl of lipids were incubated with 6 μg of purified, HA-
tagged α1 or α2 for 30 min at RT.  Lipids were spun down at 50,000 RPM.  Supernatant fractions 
were collected and both the supernatant and pellet were resuspended with SDS sample buffer to 
equal volumes.  Equal volumes of each were then loaded onto SDS-PAGE, followed by Western 
analysis using anti-HA antibodies. 
 
Immunoprecipitation of proteins.  HeLa cells were first transfected with α1-HA or α2-HA 
constructs and then whole cell lysates were prepared with ice-cold RIPA lysis buffer containing 
protease inhibitor cocktail (Roche).  Lysates were then cleared of debris through centrifugation, 
followed by pre-clearing using both rabbit/mouse serum and Protein A/G slurry for 1 h on ice.  
After removing Protein A/G slurry, a second round of pre-clearing using only Protein A/G slurry 
was conducted for 1 h at 4ºC.  Supernatant was then removed and incubated with anti-HA 
antibody for 3 h on ice, followed by capture using Protein A/G agarose for 1.5 h at 4ºC with 
gentle rocking.  Agarose beads were then collected and processed for SDS samples and 
subsequent SDS-PAGE and silver staining using standard protocols. 
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